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RHSC Royal Hospital for Sick Children
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VTM viral transport medium
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SUMMARY
During the period January 1987 to June 1989, 100 infant deaths (64 
males, 36 females) aged between 17 days and 53 weeks (mean age, 16.4 
weeks) were brought to the Pathology Department, R.H.S.C., Glasgow for 
post mortem examination. A similar group of 98 infant deaths (62 
males, 36 females) aged between 2 days and 63 weeks (mean age, 22.6 
weeks) were examined at the Paediatric Pathology Department, R.H.S.C., 
Edinburgh. These cases were categorised as suspected cot death cases 
using the individual pathologist*s classification. Twenty seven 
paediatric deaths (14 males, 13 females) aged between 3 weeks and 3 
years (mean age, 1.4 years) presenting with a variety of surgical 
disorders, mainly cardiac were investigated in parallel with the cot 
death group.
The 100 cot death cases from Glasgow over the two year period 
were collected from a substantial study population of 2.5 million 
persons (out of a total population of 5 million). A limited 
epidemiological analysis was carried out on the cot death cases from 
the two Scottish paediatric centres. The location of cases showed a 
random distribution pattern throughout both Glasgow and Edinburgh, with 
the highest numbers of cases present in areas of densely populated 
housing schemes, G33 Blackhill, G34 Easterhouse, EH16 Liberton and EH4 
Silverknowes/Clermiston generally regarded as areas of social 
deprivation. However, the study did not include details of social 
conditions and status of the cot death families.
19
Seasonal distribution of cot death cases revealed a winter predominance 
(December to April) although the Glasgow cases tended to have higher 
numbers of cases in January and September, occurring earlier than the 
Edinburgh cot death cases. Case numbers in the summer months, June 
through to August were low in both populations. The number of infants 
dying of cot death at 9-16 weeks of age was greater than at any other 
period in the first year, with the mean age of 18 weeks. Mild 
respiratory infection was a clinical feature obtained by parental 
interview in 60% of cot death cases prior to death, although there did 
not appear to be any pathological evidence to support these findings.
A comprehensive study of the respiratory tract was included in the 
project. Exfoliated cells from nasopharyngeal aspirate (NPA) and also 
impression smears of various levels of the respiratory tract (pharynx, 
larynx, trachea, main bronchus, bronchioles, and peripheral lung) were 
investigated for the presence of respiratory viruses using a number of 
monoclonal antibodies incorporated in a direct immunofluorescence 
assay. Samples collected at autopsy from cot death cases and 
paediatric deaths for viral isolation included heart, lung, brain 
(temporal lobe), kidney, mediastinal lymph node, mesenteric lymph node, 
recto-sigmoid loop, post-nasal swab, urine, heart blood and 
cerebrospinal fluid. The stool samples were tested by ELISA for the 
presence of rotavirus antigen, and positives confirmed by electron 
microscopy.
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Results revealed a 16% virus positivity rate for Glasgow cot deaths,
38% for Edinburgh cot deaths and 18% in paediatric deaths. A wide 
range of viruses were isolated/detected including influenza A, RSV, 
adenovirus, parainfluenza type 3, rhinovirus, rotavirus, echovirus and 
poliovirus. The respiratory viruses represented the largest number of 
isolates in cot death cases with the exception of the poliovirus group. 
The polio virus isolates were almost certainly vaccine strains as 50% 
of infants were immunised prior to death.
The serum phase was obtained from the heart blood and used in 
complement fixation testing and indirect immunofluorescence testing to 
detect antibodies against a range of viruses. These studies were 
unrewarding giving essentially negative results. Bacteriological 
examination of the cot death samples was also unrewarding as no 
positive correlation could be made between isolate and the pathological 
report.
An immunoradiometric assay was used to detect the presence of alpha 
interferon (IFN- oi ) in samples of NPA, serum and CSF obtained from cot 
death cases. This novel approach was taken to question the infection 
hypothesis with respect to viral disease, as this assay has already 
been shown to be both sensitive and specific for IFN- oi determination 
in biological fluids and to be a good marker of virus disease. The 
assay evaluated on control and cot death samples was shown to be 
reproducible and specific throughout the duration of the study. The 
specificity of the assay on cot death samples was determined by a
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neutralisation/blocking step, and data is provided to demonstrate that 
interferon present in specimens could be removed prior to testing.
The IFN- oi value in NPA samples, was positive at levels >10 IU/ml in 
35% of cases, while the values obtained from paediatric death samples 
were found to be substantially lower. In a comparative study of NPA 
IFN- oC values from paediatric cases of bronchiolitis, upper respiratory 
tract infection, pneumonia and chronic lung disease, the latter two 
clinical conditions showed a similar range of IFN- o( levels to those 
observed in cot death cases. It is possible that cot death cases are 
in the earliest stages of acute lower respiratory tract infection. Age 
distribution and post mortem interval were analysed with respect to 
IFN- data and no positive correlation was found for these parameters. 
Analysis of virus positive and virus negative cot death cases 
demonstrated raised IFN- levels in both groups of infants. Thus a 
positive correlation between virus positivity and high IFN- oC values 
could not be made. It is possible that the limitations of conventional 
methods of virus detection account for this discrepancy and IFN- oC 
tests may be a better guide to virus infection than currently available 
routine methods alone. Lung sections from various levels in the 
respiratory tract were investigated for the presence of IFN- o( by an 
immunoperoxidase technique. Gells of the intra-alveolar macrophage 
lineage were confirmed as the cells expressing IFN- oi in lung tissue.
By further study,’KP1 - positivity (see page 16) was 
observed within the macrophage cells in the peripheral lung. The 
intensity of staining for IFN- o< and KPI was graded from 1 - 4.
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The higher grading values corresponded to the pathologists report of 
congestion and oedematous infiltrate within the lower lung. However 
a positive correlation of in-situ IFN- o( detection in peripheral lung 
and IFN- o< by IRMA in NPA's could not be made.
IFN- d  in CSF and serum samples from cot death cases and paediatric 
deaths was detected only at low levels of <10 IU/ml. Levels were not 
shown to be statistically significant between either of the study 
groups and the significance of its presence in CSF and serum at these 
levels is further considered.
The study uses the novel approach of IFN- oi detection in cot death 
samples to further investigate the infection hypothesis. The combined 
epidemiological and interferon data suggests that an "as yet 
unidentified" microorganism, infecting the respiratory tract is still a 
possibility despite the absence of clinicopathological data to support 
this hypothesis. Although the field remains open for an explanation of 
the Cot Death Syndrome the data in this thesis has suggested that 
further infection-orientated programs are required before dismissing 
the infection hypothesis.
23
CHAPTER 1 
INTRODUCnON 
Part 1
Cot death is one of the major causes of mortality in infants during the 
first year of life in the developed world (Peterson et al., 1979). 
Sudden and unexplained death has become of increasing medical and media 
interest as the more common causes of childhood mortality have been 
substantially reduced. Despite improvements in social conditions and 
availability of medical care these benefits do not seem to have reduced 
the pattern of cot death. Historically, sudden death in infants formed 
a small proportion of the total number of infant deaths. At the turn 
of the century, the infant mortality rate was 150 per 1000 live births 
(15%) of which 148 of the 150 deaths were due to congenital 
malformation, infection and malnutrition and 2 deaths per 1000 (0.2%) 
were attributable to sudden unexplained death. Recent rates indicate 
that the infant mortality rate is 10 per 1000 live births (1%) of which 
6 infants per 1000 are likely to die due to low birth weight and 
congenital defects. The remaining 4 deaths per 1000 live births 
occurred in infants between one month and one year of age, half of 
which are due to congenital abnormalities and infection and the other 
half, 2 deaths per 1000 live births occurred suddenly and unexpectedly 
(0.2%) (Pharaoh & MacFarlane, 1982).
24
Until a better understanding of the aetiological aspects of cot death 
have been elucidated, it is unlikely that there will be a decrease in 
the annual statistics for this syndrome.
1.1 .1 HISTORICAL PROFILE OF GOT DEATH
For thousands of years, the concept of "overlaying" of a child in their 
parents' bed was a popular explanation for sudden infant death. An 
early reference can be found in the Old Testament (First Kings, Chapter 
3, vs19). At this time, infanticide was extremely common and no 
attempt was made by the authorities to distinguish between deliberate 
suffocation and overlaying. A retrospective study of the slave 
children of Virginia, USA suggested that the figures attributable to 
"overlaying" (16-20% of infant deaths less than one year of age) 
mimicked those of the modem term Sudden Infant Death Syndrome (SIDS) 
(Savitt, 1979).
Pathological investigation is only a recent innovation in the 
investigation of cases of sudden infant death. Earlier this century, 
several eminent physicians thought that the thymus was grossly enlarged 
in cot death cases in comparison to cases dying of more common illness 
- malnutrition and infection (Jessop, 1905). However, Weme and Garrow 
(1953) deduced that the thymus in these earlier cases of sudden death 
were in fact the normal size gland, and that enlargement of the thymus 
is not a consistent feature of this syndrome.
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Daring the Second World War, one pathologist suggested that "dried 
milk kills babies" as the inhalation of milk caused a "carburettor 
effect of the larynx". However, this hypothesis was refuted on 
subsequent investigation by the Ministry of Health. Barrett noted that 
children dying from terminal anoxia regurgitated their stomach contents 
but concluded that the presence of milk in the airways was not a 
primary mechanism for the cause of death. In later studies, the theory 
of a possible sensitisation to cow's milk was also investigated as 
reported by Coombs (1974).
Over the past thirty years, other research areas have been explored. 
Discussions on various aspects of cot death research were held at the 
International Conferences in 1963 and 1969 (Bergman et al., 1970) in 
Seattle, USA and at the symposia in Cambridge, 1970 (Camps & Carpenter, 
1974), Toronto, 1974, Baltimore, 1982 and Italy, 1987 (Schwartz et al., 
1988). Various hypothesis on aspects of epidemiology, immunology, 
genetics, excess and deficiencies in metabolism were debated which has 
formed the foundation of numerous studies since.
A number of national organisations were set up to provide support for 
the families of victims and organise research funding specifically for 
SIDS. In the UK, The Foundation for the Study of Infant deaths and the 
Scottish Cot Death Trust were established in 1971 and 1985 
respectively.
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1.1.2 MODERN DEFINITION OF SODDEN INFANT DEATH SYNDROME (SIDS)
In the literature several terms are used synonymously; "cot" death in 
Britain, "crib" death in the USA, sudden unexpected death in infancy 
(SUDI), sudden unexpected infant death (SUID) and now more commonly the 
term Sudden Infant Death Syndrome (SIDS).
J.B. Beckwith at the International Conference held in Seattle, 1969 
defined the sudden infant death syndrome as "The sudden death of an 
infant or young child which is unexpected by history and in whom a 
thorough necropsy examination fails to demonstrate an adequate cause of 
death".
The definition is primarily a diagnosis of exclusion and therefore is 
limited by the current methods of pathological investigation and our 
present understanding of the syndrome. The term "sudden infant death 
cause unknown" was first accepted for this syndrome as the natural 
registerable cause of death in England and Wales in 1971. It was not 
until 1979 that the Sudden Infant Death Syndrome (SIDS) was included in 
the International Classification of Diseases, in the 9th revision.
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1.1.3 INCIDENCE
Worldwide incidence rates for the Sudden Infant Death Syndrome are 
documented in Table 1.
Until relatively recently, few studies have been undertaken to 
ascertain the true incidence of sudden infant death, largely due to 
unreliable registration of SIDS as a cause of death and the lack of 
identifiable clinical or laboratory markers for this syndrome.
As post-neonatal mortality in the UK has decreased since the Second 
World War, cot death cases now account for more than half of the deaths 
recorded (Pharaoh & MacFarlane, 1982). Figures for cot death collated 
for the UK (Fedrick, 1973, Mason et al., 1980) and Australia (Beal, 
1972, Hilton & Turner, 1976) show a general trend of between 1.6-4.1 
per 1000 live births. In comparative studies these results were 
similiar to those calculated for North America, 2.1 per 1000 live 
births (Valdes-Dapena, 1980). The post neonatal mortality rate for 
Sweden has been recorded at 3.3 per 1000 live births and this low rate 
was reflected in the value of 0.6 per 1000 live births attributable to 
cot death (Karlberg et al., 1977).
Two studies carried out in Denmark gave conflicting results: Beiring-
Sorensen (1978) observed a rate of 0.9 per 1000 live births but Zachau-
Christiansen (1975) from a smaller study detected a mortality rate of
2.7 per 1000 live births. Taylor and Emery (1988) in the UK reported
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TABLE 1
Worldwide Incidence Rates for Sudden Infant Death Syndrome 
(Fitzgerald, 1988)
COUNTRY YEAR AUTHOR SIDS 
Incidence/1000 
Live Births
Australia 1988 Newman 1.9 - 3.7
Great Britain 1985 Golding et al. 2.0 - 2.78
Canada 1971 Kraus et al. 3.0
Denmark 1978 Biering-Sorensen et al. 0.92
Finland 1986 Rintahaka & Hirvonen 0.31 - 0.51
France 1984 Wagner et al. 2.71
Germany 1980 Althoff 1.3
Ireland 1985 Matthews 2.67
Italy 1988 Rusinenti et al. 0.8 - 2.6
New Zealand 1986 Hassall 1.9
Scotland 1985 Ameil 2.71
Scotland 1988 Bartholomew & MacArthur 2.9
Sweden 1987 Norvenius 0.41 - 0.9
United States 1979 Peterson et al. 1.7 - 3.06
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the results of a prospective study carried out between 1977-1987 which 
showed an increasing rate of unexpected infant death. The UK post- 
perinatal death rate increased in 1986 due to the increase in numbers 
of deaths registerable as SIDS. Although, the authors reported that 
this increase may be due to "random variation", they noted that the 
increase coincided with a steady rise in the unemployment rate and 
minor diseases in families. The same authors concluded that cot deaths 
were seen in all socio-economic groups and continued while the death 
rate for children with serious disease showed a downward trend.
Recent figures for Scotland (Ameil et al., 1985) from a study 
population of 244 infants indicated an infant mortality rate of 11.3 
per 1000 live births, 2.7 per 1000 live births (27%) of which were 
attributable to sudden infant death.
1.1.4 EPIDEMIOLOGY
Epidemiological studies have assisted in the identification of an "at 
risk" group of infants within the population that are shown to be 
susceptible to cot death (reviewed by Kelly & Shannon, 1982). A number 
of Western countries have carried out substantial analysis of their 
SIDS data as indicated in Table 2.
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TABLE 2
Published Epidemiological Data Related to SIDS
COUNTRY YEAR AUTHOR
Australia 1988 Newman
Europe
Britain 1965 Cameron & Asher
1969 Strimer et al.
1971 Fedrick
1985 Golding et al.
Finland 1986 Rintahaka & Hirvonen
France 1984 Wagner et al.
Germany 1980 Althoff
Italy 1988 Rusinenti et al.
Scotland 1985 Ameil et al.
Scotland 1987 Bartholemew et al.
Sweden 1987 Norvenius
United States
1976 Naeye et al.
1979 Standfast et al.
1980 Peterson
1980 Valdes-Dapena
1988 Hoffman et al.
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Area/Place of Death
Although the syndrome has been termed "cot" death the place of death 
was not always the home or cot. Fedrick recorded 65% of cases 
occurred at home, 22% in hospital and 5% elsewhere. Peterson &
Beckwith (1974) examined the possibility that hospital stay may protect 
against the likelihood of cot death and concluded that this was unlikely. 
Population studies have shown an increased incidence of cot death in 
the city environment compared to rural districts (Emery et al., 1959). 
Figures collated for the UK, Australia and Northern Ireland have shown 
similar trends but these were not noted in US surveys (Bergman et al., 
1970). However, one large survey in the USA, detected an increased 
incidence on the Pacific Coast compared to the Atlantic. In Nebraska, 
the risk of cot death increased with altitude. No firm conclusions 
could be drawn from these results due to other risk factors also 
apparent in the study population (Getts & Hill, 1982).
Socio-economic Conditions
Social class status is not positively related to the likelihood of cot 
death (Fedrick, 1973), and this conclusion has been borne out by 
subsequent studies.
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Age Distribution
Conclusions concerning age distribution in cot death were made on data 
collated from large studies (Jorgensen et al., 1979, Naeye et al., 
1977). Althoff (1980) summarised his findings on 292 cases studied in 
Cologne observing that the majority of cases occurred in the first year 
of life, 89.1% before one year of age, 66.8% before the end of six 
months and 52.4% during the first four months of age. There was an 
increased risk of cot death as age increased from birth until 1 year of' 
age (Jorgensen et at., 1979). The majority of deaths occurred between 
4-20 weeks with a peak incidence in the 3rd month (Valdes-Dapena,
1968).
Sex Differences
A male preponderance (1.6:1 male:female) was detected 
(Ameil et al., 1985). Analysis of cot death cases 8-15 weeks of age 
showed61.5%of boys died compared to 36% of girls. This finding was 
also noted for cot death cases by Arsenault (1980) during a study of 
maternal and antenatal factors.
Seasonal Variation
Published data has shown that the frequency of cot death increases in 
the Winter months in temperate climates (Nelson et al., 1975).
However, a study carried out several years later indicated that
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investigators had not taken into account that more babies are b o m  at 
certain times of the year (Farber & Chandra, 1978). In Britain the 
peak birth rate is in the Spring but any variations in the number of 
infants b o m  are slight compared to the numbers of sudden deaths in 
winter months. Zoglo and oo authors (1979) concluded that variation of 
birth rate with season made no difference to the winter excess of cot 
deaths. Several investigators have attempted to correlate outbreaks of 
infectious disease (Nelson et al., 1975), air pollution levels (Kraus 
et al., 1967) and meteorologic cycles (Bonser et al.,1978) with the 
incidence of cot death in the community.
1.1 .5 MATERNAL FACTORS
An American study undertaken by Arsenault (1980) noted that cot death 
occurred more frequently to mothers who are young i.e. 20 years of 
age particularly those who may have experienced previous fetal loss.
The more children already bom, the greater the risk of SIDS. Also 
Naeye (1976) reanalysed data from the US Collaborative study and 
indicated that a decrease in maternal blood pressure during the third 
trimester of pregnancy enhanced the likelihood of a cot death. The 
incidence of haemorrhage and anaemia were investigated but did not show 
any significant differences between the cot death group and the 
controls (Beal, 1987).
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Drug Addiction
There are several studies carried out in the States relating drug 
addiction and SIDS incidence (Chavez et al., 1979, Finnegan, 1979,
Rosen & Johnson, 1988). The chance of SIDS occurring to an opiate- 
addicted mother was enhanced by 20% i.e. by a factor of 5.
Murphy et al. (1982) in Cardiff indicated that the incidence of SIDS 
increased when the mother smoked during pregnancy. A non-smoker 
carried a risk value of 0.6 whereas a smoker of more than 20 cigarettes 
per day rose to 2.7 (Toubas et al., 1986). Two trans Atlantic studies 
showed that 68% and 39% of mothers had smoked during pregnancy compared 
to 39% and 21% respectively in the control groups (Naeye et al., 1976).
1 .1.6 METABOLISM
Although studies have been carried out to assess levels of manganese, 
cobalt, iodine, iron, copper, zinc (Caddell et al., 1977, Erickson,
1983) no firm evidence exists as yet to suspect an aetiology of trace 
element deficiency or overload. Patrick & Logan (1988) published data 
on an investigation of the concentration of 27 amino acids in the 
vitreous humour from 120 cot death cases and concluded that their 
results could not show an aminoacidopathy in cot deaths.
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Harpey and coworkers (1986) have suggested a relationship between fatty 
acid-oxidation defects and cot deaths. Eight siblings of cot death 
cases and 2 "near-miss" cases were studied. None of the cases were 
clinically normal and presented with an abnormal odour due to multiple 
acyl CoA dehydrogenase deficiency (1 case), ethylmalonic-adipic 
aciduria (4 cases) and carnitine deficiency (1 case). This work is 
still preliminary and further evidence is required to show the 
importance of this work to the large number of cases of cot deaths seen 
each year.
1.1.7 PATHOPHYSIOLOGY
Beckwith and colleagues (1970) highlighted the need for a detailed 
post-mortem investigation of infants (< 1 year of age) who die suddenly 
and unexpectedly.
Anatomical studies have concentrated on the cardio-respiratory system. 
The respiratory tract histology has been extensively investigated (Tapp 
et al., 1975). Inflammation in the respiratory tract (trachea, bronchi, 
lungs) was categorised into four groups:
1. Acute tracheobronchitis, acute bronchitis both which cause death,
2. Less severe abnormalities presenting with oedema but no necrosis,
3. Minor lesions
4. No inflammation
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Fran the 139 cot death cases, one third showed minor inflammation in 
lung parenchyma (group 3). Apnoea is a respiratory pattern abnormality 
common in preterm infants, although little is known of the physiologic 
mechanism, Steinschneider (1972) reasoned that apnoea or hypoxia may 
play a role in the sudden death of an infant. A number of papers 
appeared in the literature in the form of supportive evidence for the 
apnoea theory with the identification of "tissue markers" for hypoxia 
and hypoxaemia (Naeye, 1973, Naeye et al., 1976). Studies of 
respiratory control have identified abnormalities in groups at risk of 
cot death: prolonged sleep apnoea (Guilleminault et al., 1976),
excessive periodic breathing (Kelly & Shannon, 1977) and impaired 
arousal responsiveness to hypercarbia or hypoxia (Hunt, 1981).
Some protective response to these respiratory abnormalities would be 
expected to prevent sudden death during sleep.
An impaired arousal responsiveness would not necessarily be sufficient 
to cause cot death unless other factors caused sleep-related asphyxia. 
Brainstem structures may be affected by hypoxia hence altering the 
infant's autonomic control of ventilation and cardiac rhythm.
Surfactant decreases the surface tension in the alveoli in the lungs 
and prevents collapse after birth. Data published by Morley and 
colleagues (1982) indicated that there was a decrease in the phospholipid 
and dipalmitoylphosphotidylcholine content in surfactant from lungs of 
SIDS victims compared to a control group. Several years later, Talbert & 
Southall (1985) suggested that abnormal surfactant content in SIDS may 
cause pulmonary atelectasis with hypoxemia during lung development.
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1,1.8 CARDIAC
A prolonged QT interval may be related to SIDS. Gordon and co-workers 
(1982) analysed the heart rate and respiratory activity in eight babies 
who later died of cot death, and also included a control group in the 
study. They concluded that the- eight infants who died had a defect in 
cardiorespiratory regulation. Marino and Kane (1985) documented 
results on the conduction system of seven infants who died suddenly. 
Schwartz and colleagues (1982) tested the sympathetic imbalance theory 
on new b o m  infants over a range of age levels. The infants with 
cardiac arrhythmias or prolonged QT interval were tested. Thirteen 
thousand five hundred infants were enrolled in the study and data on 
10,000 infants was collated. Ten SIDS deaths and 4 non SIDS deaths 
were reported. The 4 non SIDS victims had QT intervals within normal 
limits and 6 out of 10 (60%) SIDS victims had a prolonged QT interval. 
The risk factor of SIDS is 30 cases per 1,000 live births (Segantini 
et al., 1986).
The data collected indicated that 30% of infants who subsequently
became a SIDS victim may have a prolonged QT interval on the fourth day 
y
of life and the investigators suggested this to be a valuable marker 
for risk of SIDS in infants (Schwartz, 1984). A development abnormality 
in the sympathetic nervous system was postulated (Haddad et al., 1981). 
The increased likelihood of arrhythmias linked with the autonomic 
nervous system and sudden cardiac death was reviewed by Schwartz and
Stone (1982).
c’ ■ .
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1.1.9 INFECTIVE ASPECTS
Following the upsurge in research in the 1960’s, the role of infection 
as a possible mechanism in the pathogenesis of cot death was widely 
debated. Epidemiological evidence supported the view that infection 
may be a trigger mechanism in the final pathway leading to sudden death 
in infants (Urquhart & Grist, 1972, Uren et al., 1980).
Several epidemiological features associated with cot death have 
strengthened evidence for a viral aetiology; high seasonal incidence 
between November - March, coinciding with the respiratory epidemic in 
the community (Scott et al., 1978), respiratory and enteric infection 
apparent to parents and babysitters prior to death (Williams et al.,
1984), cot deaths affecting twins dying on the same night (personal 
observation) and the increased frequency in cot deaths in larger 
families.
Gold and coworkers (1961) attempted viral isolation from post mortem 
tissue collected from a group of 48 sudden and unexpected infant 
deaths. Twelve viruses (25%) were isolated from the pharynx, stool and 
central nervous system tissues. These agents were identified as 
members of the enterovirus group i.e. Coxsackie A virus, poliovirus 
type 3.
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A subsequent study carried out in Phoenix, Arizona, USA reported the 
isolation of viruses from 10 infants who died suddenly and 
unexpectedly. A total of 45 specimens including brain, lung, liver and 
stool were investigated for the presence of virus. Viruses were 
detected from one site in 7 (15%) of the 10 infants studied. ECHO virus 
types 7 and 22 and poliovirus types 1 and 2 were isolated from the stool 
specimens and tissues (Moore et al., 1964).
A four year study of 97 sudden infant deaths in New York, USA 
incorporated a "control" group of 33 infants aged 2 years of age who 
died of congenital heart defect, pneumonia and accidental injury. 
Fourteen (14%) viruses were isolated from the 97 sudden infant deaths 
and 1 (3%) virus from the "control" group. The viruses isolated were 
from the enterovirus group i.e. coxsackie A and B viruses, poliovirus 
and echovirus (Balduzzi & Greendyke, 1966).
Larger studies have shown increased isolation rates from infants dying 
suddenly and unexpectedly compared to explained deaths (Ray & Beckwith, 
1970). A study of 72 sudden infant deaths and 34 explained deaths 
indicated a 42% and 29% viral isolation rate for the two study groups. 
The viruses isolated were approximately one half enteroviruses and one 
third adenoviruses. The authors concluded that the presence of virus 
in tissue was not sufficient clinical evidence to suggest an 
overwhelming viraemia (Urquhart & Grist, 1972).
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As the isolation and detection of viruses became more specific and 
sensitivity was improved, the more fastidious respiratory viruses; 
influenza virus types A and B, parainfluenza virus types 1, 2, 3, 
respiratory syncitial virus (RSV) were detected in the cot death cases and 
in control groups (Scott et al., 1978). With the introduction of 
fluorescence antibody techniques by Gardner and colleagues (1970) 
in Newcastle-upon-Tyne, viruses have been identified in the respiratory 
tract of cot death cases at post mortem. Gardner identified RSV in 
impression smears and frozen sections of lung tissue prepared post 
necropsy examination.
Ferris and colleagues (1973) several years later, investigated the 
relationship between viruses and the histological picture in lung 
sections in cot death. The pathological findings from the lung tissue 
could be categorised into three groups:
Group 1 were characteristic of cot death cases indicating varying 
degrees of pulmonary congestion, alveolar haemorrhage and generalised 
alveolar oedema. Also present were petechial haemorrhage.
Group 2 showed the typical histological appearance of bronchitis that 
being inflammation affecting bronchioles with necrosis of bronchiolar 
epithelium.
Group 3 was typical of bacterial bronchopneumonia where inflammation 
was widespread in the bronchi and bronchioles.
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Fifty one cot death cases were included in the study and the results 
indicated that 33 children were placed in group 1 and had no virus 
isolated. Sixteen children were placed in group 2 and in 13 children (25%) 
virus isolates were noted. Two children were categorised into group 
3 and no viruses were apparent in this group. The virus and 
histological association in Group 2 was statistically significant. The 
viruses detected were RSV, influenza virus type A, parainfluenza virus 
type 3, adenovirus and rhinoviruses. Several observations made from 
these findings suggested that the respiratory viruses detected in the 
study were those associated with acute respiratory illness in childhood 
which could imply that viruses play a part in the process leading to 
death. The limitation of the study was the lack of a suitable 
"control" group.
Scott and co-workers (1978) detected RSV (11%) adenovirus (7%) and 
parainfluenza virus type 3 (3%) by immunofluorescence techniques 
in 52 cot deaths. The study revealed the presence-pf a respiratory 
virus infection in 25% of cot deaths. The overall viral isolation rate 
for sudden infant deaths in these studies ranged from 15-44%.
The incidence of cot death has been linked to the peak of the RSV 
epidemic in the community (Scott et al., 1978). The average age of RSV 
cases (mean age 3-4 months) has also been shown to be comparable in cot 
death cases (Hall et al., 1979). Apnoea has been observed as a 
presenting feature of RSV in 15-25% of infants and epidemiological
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studies have shown this also to be a risk factor in cot deaths (Anas et 
al., 1982). Ray and Beckwith (1970) investigated 80 SIDS cases but 
failed to recover RSV from any of the samples tested. Brandt (1984) 
isolated RSV in 14% of the SIDS cases.
Investigators have been unable to link any one virus in the 
pathogenesis of sudden infant death although there are infrequent 
reports of such cases, for example, CMV was associated with 
interstitial pneumonitis in a cot death group. Similarly, CMV was 
detected in the brain tissue from 4 cases of sudden infant death via 
extensive pathological investigation indicating the presence of 
inclusion bearing cells pathognomic of infection (Variend et al.,
1986). Rotavirus has also been implicated in a small number (3 cases) 
of suspected cot death cases and in 2 "near miss" infants. Enzyme 
immunoassay was employed to detect rotavirus in stool and in tracheal 
aspirates. Rotavirus was identified in all 5 cases but was not 
detected in 11 non SIDS control cases in the Boston area 
(Yolkin & Murphy, 1982). The identification of more than one virus 
isolate in cot death cases, as indicated, led to the hypothesis that 
the sudden infant death syndrome was not a feature of one individual 
virus but possibly the result of the host response to a viral 
infection.
Immunisation with diphtheria-tetanus-pertussis (DTP) vaccine has been 
identified as a possible risk factor In cot death. Griffin et al., 
(1988) studied a group of 129,834 children receiving a DTP vaccine
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regime. Two hundred and four deaths were categorised as SIDS. The 
study concluded that there was no increased risk of SIDS post 
immunisation, with this 'triple' vaccine.
Theories regarding the immune response have also been suggested. Ogra 
and colleagues (1975) used a quantitative method to show immunoglobulin 
G (IgG) and immunoglobulin M (IgM) were present in lavage fluid, but 
secretory component was absent in pulmonary tissue. The levels of 
immunoglobulins G, M, D, E, A (IgG, IgM, IgD, IgE, IgA) in sera of cot 
deaths compared to a control group were not significantly different 
(Turner etal., 1975).
In a more recent study, Forsyth and colleagues (1989) indicated that in 
lung lavage specimens from 16 cot death cases high concentrations of 
IgG, IgM and to a lesser extent secretory IgA were detected compared to 
lower levels in the control samples. Positive cellular staining for 
the immunoglobulins was evident in the terminal airways and alveolar 
interstitium of cot death cases.
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No consistent aetiological approach has yet emerged which takes account 
of all the epidemiological features suspected. Several main points are 
still debated in this syndrome:
- the lack of a decrease in SIDS numbers despite progress in decreasing 
the infant mortality rate
- the lack of an identifiable infectious agent , although there is an
increase in SIDS cases during the Winter months
- a narrow age distribution with \ . male predominance noted in
cases
- an increased risk of cot death to mothers with poor pre/post natal 
care and an increase in risk to mothers who smoke.
The field is still wide open and the infectious hypothesis awaits 
either new diagnostic tests or even the discovery of a micro-organism 
as yet unidentified.
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Part 2
1.2.1 (XJREENT CONCEPTS OF INTERFERE
Interferon was discovered more than 25 years ago by Isaacs and 
Lindenmann (1957) during a study of viral interference. The work 
involved the incubation of heat inactivated influenza virus with chick 
chorioallantoic membrane. The cells were then washed and the monolayer 
challenged with live influenza virus. An interference phenomenon was 
observed and a hypothesis formulated suggesting that an interfering 
material was released into the fluid from the uninfected cells thus 
preventing subsequent infection. The diffusible substance produced was 
named 'interferon1. The historical discovery of interferon is reviewed 
by Burke (1985).
Interferon produced from a variety of cell types was shown to exhibit 
the property of species-specificity (Tyrell, 1959). Initial 
experiments suggested that the interferon was a single substance 
degradable by proteolytic enzymes, hence protein in nature. Detailed 
study using human cells enabled workers to describe the interferons as 
a family of proteins and glycoproteins secreted by virus infected cells 
(Beale/1971).
It is now clear that there are at least three antigenically and 
chemically distinct classes of each interferon determined by the cell 
type from which they are produced: leucocyte for IFN- c< , fibroblast
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for IFN- p  and lymphocyte for IFN- # (Stewart et al., 1980).
Although the precise biological role of each interferon species remains 
unclear, these interferons have been shown to exhibit diverse 
biological properties: antiviral action, cellular regulation, inhibition 
of cell proliferation and immunomodulatory capabilities (Moore, 1984).
The type of interferon produced depends on the method of induction of 
which there appears to be two types. Type 1 is induced by viruses, 
polyribonucleotides, endotoxins and comprises human leucocyte and 
fibroblast interferon. Significant quantities of human interferon- o( 
were first made by exposure of buffy coat cells to Sendai virus, in 
vitro. Type 2 or "immune" interferon is produced when sensitised B or 
T lymphocytes are exposed to a suitable antigen. This Type 2 
interferon has been compared to lymphokines and acts as an effector 
substance (Ho, 1982).
Interferon <x, P and ^  have now been synthesised by recombinant DNA 
technology and the resultant recombinant interferon preparations have 
contributed to the current knowledge of the biochemical and molecular 
components of natural interferon. Human IFN- oC was purified using high 
performance liquid chromatography (Rubinstein et al., 1979). From gene 
and protein studies, more than 24 species of IFN- oi have been 
identified. The molecular weights of these species range from 16000 to 
27000 daltons (Pestka, 1984).
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IFN- P was purified by Knight and colleagues (1984) from human 
diploid fibroblast cells. Two species of IFN- p have been isolated 
both of molecular weight 20000 daltons. The IFN- o^  species 
all contain 166 amino acids with a high degree of 
conservation whereas the homology with IFN- species 
[ is only 45%. j
A single gene for IFN ^  was identified by Gray et al.,(1982)
- coding for a polypeptide of 146 amino acids with a molecular i
weight of 15000 - 20000 daltons. Overall there is no 
significant homology between the three types of interferons 
(Toy, 1983).
1.2.2 INTERFERON INDUCTION DURING DISEASE
Interferon plays an important role in the host defence against disease. 
It has been suggested that interferon is the first line mechanism 
deployed by the infected host during recovery from viral infection. 
Interferon expression results in a delay in the spread of virus giving 
time for the iramuneresponseto develop and hence eradicate virus 
(Ho, 1982, Billiou, 1984).
Interferon has been detected in various human and animal tissues and 
fluids during acute viral infections. Several studies have correlated 
the presence of interferon in acute infection with the establishment of 
a viral aetiology. The possibility of a virus being implicated in
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illness of unknown aetiology has been enhanced by the presence of a 
raised interferon level (Wheelock & Sibley, 1964, Negreanu et al.,
1983, Ho Yen & Carrington, 1987).
It is clear that certain viruses are better inducers of interferon than 
others i.e., 3% in RSV cases and up to 50% in influenza A infection. A 
series of experiments with mice indicated that primary infection with 
influenza virus produced peak levels of interferon in the lungs during 
virus replication (Iwasaki et al., 1977).
Detectable levels of I F N - i n  nasal secretions during acute respiratory 
viral infection have been reported in paediatric patients where 
parainfluenza or influenza viruses have subsequently been isolated. 
However, Hall and colleagues (1978) found that all respiratory viruses 
were not all equal in their interferon induction capacity, and that 
RSV was a poorer inducer of IFN- c* than influenza in children.
Serum studies have found that IFN-^ determinations may be useful in 
establishing a viral aetiology (Matthews & Lawrence, 1979). The short 
half life of IFN-o(was suggested as one explanation for variable levels 
in serum interferon found in cases of viral infection with or without 
viraemia measured over several days. Consequently, low levels of 
interferon in sera may not be an indication of an abnormal interferon 
response to viral disease (Levin & Hahn, 1981).
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The central nervous system (CNS) is capable of an independent immune 
response to viral infection. The precise mechanism by which the host 
defence system eliminates virus from the CNS is still unclear, although 
Ichimura and colleagues (1985) have suggested that interferon may play 
an important role in cases of acute neurological illness. The IFN-cX 
levels in CSF in cases of aseptic meningitis mainly due to enterovirus 
were significantly higher in acute phase specimens compared to 
convalescent CSF. In a recent study IFN- (X was noted as a good 
indicator of virus in the CNS and hence is useful in determining viral 
from bacterial meningitis. The IFN-<X determinations in the CSF were a 
better indication of virus in the CNS than the cell count and 
conventional cell culture techniques (Ho Yen & Carrington, 1987).
Kennedy reported the presence of IFN- <X in the CSF of paediatric 
patients with acute encephalopathy. The pathogenesis of these 
encephalopathies was suggested as a feature of the host response as a 
range of viruses were detected ( Kennedy et al., 1986).
The presence of interferon in cot death cases was investigated by Seto 
and Carver (1978). The detection of circulating interferon was 
investigated as a method of identifying cases of SIDS with suspected 
viral infection where conventional laboratory investigations were 
reported as unhelpful (Ray & Hebestreit, 1972). Using a biological 
assay system, the group detected raised serum levels of total 
interferon in 3 out of 44 SIDS cases and in only 1 out of 12 of the 
control infants. Although the numbers in the study were small
50
significant differences between the groups were not found. However, 
the conclusions drawn by the researchers suggested that with the 
subsequent isolation of viruses, it m y  have been helpful to have 
measured interferon where it m y  be produced locally rather than in 
serum.
Vanacek et al., (1986) has also studied the relationship between SIDS 
and interferon. The production of IFN- P frcm fibroblasts in the 
muscle tissue of SIDS victims was determined and compared with a 
control group of accident cases. The results indicated the presence of 
IFN- f at a level of 64 IU/ml in the SIDS group and no detectable level 
in the control group (Vanacek et al., 1985, Vanacek et al., 1986).
1.2.3 HOTHRFERON ASSAY SYSTEMS
Immunoassay
Studies prior to the 1980’s to determine interferon levels in human and 
animal tissues and fluids used biological assays. These assays are 
based on the inhibition of challenge virus in culture fluids (Friedman 
et al., 1983). Biological assays measure "total” interferon effect and 
were unable to differentiate between the three species of interferon. 
The insensitivity of the biological assay i.e. limited to levels above 
10 IU/ml also prompted many investigators to look for more sensitive 
and specific methods of measuring interferon (Parry & Parry, 1981, 
Secher & Burke, 1980).
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Daubas and researchers used an inhibition assay for the detection of 
HuIFN- c< . The specimens were incubated with rabbit anti HuIFN- c* 
immunoglobin and also 1251 radiolabelled HuIFN- cK . The immune complex 
was incubated overnight and the bacterium, Staphylococcus aureus 
containing Protein A added. The radiolabelled 1251 HuIFN- o(-antiHuIFN- PC 
immunoglobin complexed with Protein A and the radioactive level 
measured in a gamma counter (Daubus et al., 1982). The assay although 
not utilising a monoclonal antibody enabled a larger number of HuIFN- o( 
species to be observed. The limit of sensitivity of the test was 10 
U/ml.
Shiozawa et al., (1986) devised a radioimmunoassay for the detection of 
circulating IFN- oi . Antibodies to IFN- ot were raised in rabbits.
The IFN- o( produced from human BALL-1 cells on infection with Sendai 
virus was radioiodinated using the lactoperoxidase technique.
The detection limit of the assay was 0.05ng/ml IFN- o< .
Radioimmunoassays using monoclonal antibodies raised to IFN- , IFN- p 
and IFN- increased the specificity of assay methods for detection of 
interferon. The production of two site immunoradiometric assay (IRMA) 
systems enabled increased rapidity of testing hence results were 
obtained within 24 hours of receipt of specimen (Wright et al., 1984).
The measurement of HuIFN- ot concentrations in serum enabled evaluation 
of an IRMA using the monoclonal antibody (NK2) specific for HuIFN- oC . 
HuIFN- oi was purified by immunoadsorption chromatography using the
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measurement of IFN- o( were indicated by the differences in the IFN- oC 
standards on testing by IRMA and bioassay. Direct comparison between 
biological and immunoassays indicated that the immunoassay was as 
reliable as the bioassay and easier to perform.
Immunocytochemistry
Immunocytochemistry (ICC), the in-situ localisation of tissue antigens 
using labelled antibodies has been utilised as an important area of 
pathological investigation.
Coons and co-workers (1941) developed the labelling of antibodies with 
fluorochrome dye - fluorescein isocyanate, to identify antigen in 
tissue. The concept that specific antigen-antibody complexes 
enabled positive identification of the relevant antigen in tissue was 
used. When activated by the appropriate light emissions in the UV 
range, fluorescein isothiocyanate (FITC) dye conjugated to antibody 
emitted a bright green fluorescent light at wavelength 490nm. An 
alternative red fluorescent dye, rhodamine isothiocynate was developed 
for identification of tissue constituents. Immunofluorescent 
techniques had several disadvantages due to instability of the label, 
expensive equipment for evaluation was required and quantitation was 
not possible. Enzyme labels such as peroxidase (Nakane & Pierce,
1966), alkaline phosphatase (Mason & Sammons, 1978) and glucose oxidase 
(Suffin et al., 1979) were suggested as alternatives to fluorescent 
dyes. Recently advances in immunogold-silver enhancement of peroxidase
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staining has increased sensitivity of detection of antigen in fixed 
tissue (Lewis et al., 1987).
Lnmunohistological investigations using fluorochrome labelled 
antibodies were performed on fresh frozen, unfixed tissue as opposed to 
formalin paraffin processed material (Coons & Kaplan, 1950). Formalin 
fixed tissue rendered tissue unsuitable for such antibody investigation. 
However, immunoperoxidase methods were developed for the detection of 
several antigens; hormones (Kuhar & Uhl, 1979), enzymes, intracellular 
immunoglobulins (Van Noorden & Polak, 1983) and hepatitis surface and 
core antigen in formalin paraffin sections. Immunoperoxidase 
techniques enabled investigation by light microscopy, permanent stain 
via deposit of 3,3'-diaminobenzidine tetrahydrochloride (DAB) 
substituted fluorochrome label.
Inmunocytochemical labelling using peroxidase was developed in three 
methods:
1. Direct: antigen in tissue was bound directly to HRP labelled
antibody and the HRP reacted with DAB substrate to produce 
a brown pigment at the site of the antigen.
2. Indirect: antigen in tissue was reacted and bound to unlabelled
antibody, treated with HRP labelled swine antibody and 
the complex reacted with DAB to produce a brown product.
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3. Peroxidase anti-peroxidase method: a sensitive double
immunoglobulin bridge was used and an unlabelled 
secondary antibody and third layer peroxidase anti 
peroxidase (PAP) antibody. The second layer antibody 
was added in excess to the primary antibody hence 
only one combining site of the secondary antibody 
was occupied by the initial antibody and thus one 
site was left free to react with the PAP complex.
Foulis and colleagues (1987) utilised the indirect immunoperoxidase 
technique to identify interferon- o( , class 1 MHC heavy chain and 
insulin in patients with Type 1 diabetes. The antibody specific to 
interferon- oC was raised in sheep using human lymphoblastoid 
interferon from the HuIFN- <XLy Namalwa cell line
(Wellferon, Beckenham, UK). The antibody was > 80% pure when tested against 
' interferon and at least eight IFN- o( subtypes identified.
Immunoblot analysis showed that the antiserum reacted with IFN-c< but
not with recombinant IFN- , thus indicating the test to be highly specific.
An immunocytochemical study was carried out by Howatson and co-authors 
(1988) using sheep IFN- c< antiserum to identify the presence of IFN-o( 
in human placental tissue. The immunocytochemical technique used was an 
indirect immunoperoxidase technique capable of determining the IFN- oC 
antigens in wax embedded tissue sections. The antibody as described by
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Foulis and co-workers was used in this study and the detection system 
was also a peroxidase conjugate identified by DAB substrate.
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CHAPTER 2
PATIENTS, MATERIALS AND METHODS
2.1.1 PATIENTS AND EPIDEMIOLOGY
One hundred infant deaths (64 males, 36 females) aged between 17 days 
and 53 weeks (mean: 16.4 weeks) were brought to the Department of 
Pathology, Royal Hospital for Sick Children (RHSC), Glasgow for post 
mortem examination and ninety eight infants (62 males, 36 females) aged 
between 2 days and 63 weeks (mean: 22.6 weeks) were similarly examined
at the Department of Paediatric Pathology, RHSC, Edinburgh as suspected 
cot death cases. These cases were included in the study group.
Cot death was defined as "the sudden and unexpected death of an infant 
who had previously been well or had only minor symptoms11 and as such 
did not conform to the standard definition of the sudden infant death 
syndrome (SIDS), see section 1.1.2.
The Glasgow cot deaths were divided into four categories after thorough 
post mortem which included full histology, selected bacterial and viral 
culture as defined by Ameil and colleagues (1982) in a previous study 
of infant mortality: group 3A, deaths in which a definite cause was
established; group 3B, subdivided into A. deaths in which definite 
findings were observed with m y  have contributed to death, B. deaths in 
which there were minor abnormalities which probably did not contribute
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to the death, group 3C, deaths in which no significant abnormality was 
found after a thorough necropsy (true SIDS) and group 3D, deaths in 
which no definite cause was known and no necropsy undertaken and group 
3E, deaths who subsequently died after a period of resuscitation. The 
Edinburgh cot deaths were similarly defined by Bartholomew and 
coworkers (1987) as group A, deaths in which a definite cause was 
ascertained, group AB, death where an associated disorder was detected 
as a cause of death, group B, deaths with an associated disorder 
present but not thought to be an adequate cause of death and group C, 
deaths in which no associated disorder was present.
The Glasgow cases separated into the categories as follows: 
group 3A (14), group 3B A (15) B (30), group 3C (38), group 3D (0) 
and group 3E (3).
Edinburgh cases were categorised in the following groups: 
group 3A (23), group 3B A (7) B (48), group 3C (20).
In separate studies:-
a) A group of 27 paediatric deaths (14 males, 13 females) aged between 
three weeks and 3 years (mean: 1.4 years) were investigated at the 
Royal Hospital for Sick Children, Glasgow. Twelve cases were 
identified as deaths occurring during or after cardiac surgery.
b) A group of 22 adult deaths (10 males, 12 females) aged between 38 
years and 90 years (mean age 69.1 years) were examined at the 
Department of Pathology, Glasgow Royal Infirmary. A variety of post
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mortem diagnosis were recorded including bronchopneumonia, myocardial 
infarction, adenocarcinoma of the bronchus, chronic lymphatic and 
chronic myeloid leukaemias.
2.1.2 SPECIMENS
Body Fluids
Nasopharyngeal aspirate (NPA) was collected by passing a feeding tube 
(5 pg) into the posterior nasopharynx through the nose and applying 
suction pressure using a 10 ml syringe. The tube containing the 
secretions was transported in a plastic universal container. These 
secretions were diluted to a concentration of 1:10 in viral transport 
medium (VTM) and centrifuged on a bench centrifuge (Heraeus Christ) at 
3000 g for 10 minutes. The resultant supernatant was aliquoted for 
subsequent viral isolation and interferon- oC assay. The pellet of 
exfoliated cellular material was examined by direct immunofluorescence 
using monoclonal antibodies to a range of respiratory viruses, see 
section 2.1.5.
Cerebro-spinal fluid (CSF) from the cot death cases and paediatric 
deaths was collected by lumbar or cisternal puncture. The CSF from 
adult cases was obtained from the space visible in front of the pons 
after parting the cerebral hemispheres. A sterile needle was used to 
remove the CSF and care was taken not to damage the small blood vessels
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and hence avoid contamination of the specimen. Virological 
investigation included viral isolation and interferon-^ assay.
The heart blood (HB) was withdrawn from the right side of the heart 
using a syringe inserted either under direct or indirect vision or 
indirectly through the fourth left intercostal space. The heart blood 
was centrifuged using a bench top centrifuge set at 2500 g for 15 
minutes in order to obtain the serum phase. Serological analysis was 
carried out by complement fixation test and indirect immunofluorescence 
tests. Aliquots of serum for interferon-testing were stored at -20°C.
Urine was obtained in small quantities by suprapubic puncture.
The small quantity of this fluid enabled storage only for interferon- o( 
assay.
Tissues
Specimens of NPA, CSF, heart blood and urine were taken prior to post 
mortem examination and samples for viral isolation were removed using 
aseptic techniques during the initial stages at autopsy prior to 
evisceration.
Samples collected for viral isolation included post-nasal swab, heart, 
lung, kidney,-brain (temporal lobe), recto-sigmoid loop, mesenteric 
lymph node and mediastinal lymph node. The stool specimen obtained
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from the recto-sigmoid loop was investigated for the presence of 
rotavirus antigen by an enzyme linked immunosorbent assay (ELISA) 
technique (Abbott Laboratories). Positive results by ELISA were sent 
to the Regional Virus Laboratory, Ruchill Hospital, Glasgow for 
confirmatory testing by electron microscopy.
2.1.3 VIRAL ISOLATION
The tissue samples were finely chopped with a sterile scalpel blade in 
Dulbecco's phosphate buffer solution (PBS) to a dilution of 1:10 and 
centrifuged in a bench centrifuge at 3000 g for 20 minutes.
0.2mls of supernatant from the tissue samples, CSF and urine, was 
inoculated into commercially prepared individual culture tubes (Flow 
Laboratories) containing the semi-continuous cell line MRC-5 (human 
embryonic lung), the primary cell line primary rhesus monkey kidney and 
a continuous cell line Hep-2. These were incubated at 37°C and 
observed for typical cytopathic effect (cpe) of viruses for a total of 
18 days and if negative, discarded.
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2.1.4 BACTERIAL EXAMINATION
Specimens collected at autopsy for bacterial investigation included 
lung fluid, intestinal swab, CSF and heart blood. The lung fluid was 
inoculated into Robertsons broth and onto a blood agar plate then 
incubated at 37 0 C in an atmosphere of 5-10% 00z for 48 hours. The 
intestinal swab was treated as a rectal specimen and inoculated onto 
MacConkey medium and Selenite medium and incubated at 37 °C for 24 
hours. XLD (xylose-lysine-deoxycholate) medium was inoculated with the 
intestinal material and subcultured at 48 hours and investigated for 
pathogens. The CSF was inoculated onto Chocolate blood agar and 
incubated at 37 ° C in an atmosphere of 5-10% CD2. for 24 hours. 
Heartblood was inoculated into aerobic and anaerobic culture bottles 
and run through the appropriate programme in the Bactec (Becton 
Dickenson NR730) for a total of seven days. Positive cultures were 
plated out and pathogens identified.
2.1.5 IMMUNOFLUORESCENCE
Exfoliated cells from the NPA were resuspended in 1 ml of PBS and 
spotted onto a multiwell test slide using a capillary dropper. The 
slides were air dried and fixed in acetone for 15 minutes.
Commercially produced fluorescein isothiocyanate (FITC) conjugated 
murine monoclonal antibodies directed against respiratory viruses;
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RSV, influenza A and B ("Imagen11, Novo Nordisk Diagnostics Limited), 
adenovirus, parainfluenza types 1 , 2 , 3  (Whittaker Bioproducts) were 
provided at a working dilution along with a relevant counterstain- 
Evans blue. Monoclonal antibody (12 pi) was placed on the acetone 
fixed exfoliated cells and incubated in a humidified chamber at 37° C 
for 30 minutes. The slides were washed in PBS for 5 minutes, distilled 
water for 5 minutes and allowed to air dry before examination under the 
oil power field of a fluorescence microscope (Nikon Episcopic- 
Fluorescence attachment EF-D). The cells positive for the appropriate 
viral antigen gave the characteristic bright green expected from the 
fluorescein conjugate against a red background.
2.1.6 CYTOSPIN PREPARATIONS/IMPRESSION SMEARS
At autopsy, sterile swabs of six areas of lung tissues (pharynx, 
larynx, trachea, bronchus, bronchioles and peripheral lung) were 
obtained and placed into plastic universals containing 2 mis of PBS. 
These specimens were vortex mixed, the swabs discarded and the 
suspension centrifuged at 3000 g for 15 minutes.
The cell pellet was resuspended in PBS to a dilution determined 
by examination of one drop of suspension under low power (x 10) 
microscopy. A few drops of suspension were added to the sample chamber 
and spun at 1000 g for 10 minutes in a Shandon Cytospin 2. This method 
deposited cells evenly over a small area of a glass slide without 
distortion or cell damage. The slides were air dried and fixed in
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acetone for 15 minutes.
Impression smears were also collected at autopsy from the six 
levels of lung tissue already defined in the cytospin preparation 
method. These slides were air dried and fixed in acetone for 15 
minutes. Both cytospin preparations and impression smears were 
investigated for the presence of respiratory viral antigen by direct 
immunofluorescence, for method see section 2.1.5.
2.1 .7 SEROIOGICAL ANALYSIS
The serum samples were tested for the presence of antibody titres to a 
range of viral antigens; mumps, measles, herpes simplex virus(HSV), 
cytomegalovirus (CMV), varicella zoster virus (VZV), RSV, adenovirus, 
using a direct immunofluorescence technique. Test slides with the 
appropriate cell overlay were produced by growing virus to a suitable 
infective level in cell culture flasks. A typical cytopathic 
effect (cpe) in cell culture was observed using the following 
techniques:
1. RSV, adenovirus were absorbed onto a monolayered 80cm2' flask of 
Hep-2 cells for one hour and the cells maintained in minimal 
essential medium (MEM) supplemented with 1% foetal calf serum 
(FCS), penicillin/streptomycin and glutamine.
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2. Mumps and measles infected cells were cocultivated with an 80 an2 
flask of Vero cells for each virus and maintained with MEM 
supplemented with 10% FCS, penicillin/streptomycin and glutamine.
3. HSV was absorbed onto an 80 cm2' flask of Vero cells for one hour and 
maintained with the appropriate medium (as above), for Vero cell 
line.
4. Stock CMV and VZV were used to infect an 80 cm2 flask of MRC-5 cells 
and observed for cytopathic effect.
Cell suspensions for test slides were produced by washing the 
monolayer in PBS, eluting the monolayer with trypsin/versene and 
washing in PBS by centrifugation. The infected cells in suspension 
were set at an appropriate concentration by examination of one drop of 
cell suspension under low power microscopy (x 10). The cells were 
transferred onto multiwell slides using a capillary dropper. The slides 
were air dried and fixed in acetone for 15 minutes. Storage in the 
freezer at -20 ° C and quality control of the slides was carried out 
every month.
A series of doubling dilutions (neat, 4, 8, 16, 32, 64, 128, 256 units) 
of the serum sample were obtained and 12.5 pi of the appropriate 
dilution (IgM 4 units, IgG 8, 16, 128, 256 units) spotted onto the well 
containing the viral antigen. The slides were incubated in a humidified 
chamber at 37 0 C for one hour. The slides were washed thoroughly in PBS 
for 5 minutes and distilled water for a further 5 minutes. After air
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drying, 12.5 jil of the anti-human conjugated, IgG (1:30) and IgM (1:30) 
(Scottish Antibody Production Unit, Law Hospital) with Evans Blue 
counterstain was placed on the wells. The slides were incubated for 30 
minutes at 37°C and washed as previously described. The slides were 
examined under oil immersion lens (x 50) of a fluorescence microscope 
(Nikon Episcopic Fluorescence attachment EF-D).
If there was sufficient serum, an aliquot was sent to the Regional 
Virus Laboratory, Ruchill Hospital, Glasgow and latterly to the Virus 
Laboratory, Department of Microbiology, Glasgow Royal Infirmary for 
viral titres by the complement fixation test (CFT).
2.1.8 ALPHA 3MERFER0N ASSAY
Interferon-o( levels were measured using a commercially produced two 
site immunoradiometric assay (IRMA) (Novo Nordisk Diagnostics Limited, 
formally Boots Oelltech Limited). The test incorporated a monoclonal 
antibody (Yok5/19) specific to leukocyte IFN- and radiolabelled with 
1251. After further incubation with a polyclonal anti IFN- oC bound to 
a solid phase (sepliarose), the unbound IFN- was separated from the 
bound fraction using a non centrifugal sucrose separation procedure 
("Sucrosep"). The principle of the assay is diagrammatically 
represented in Figure 1.
INTERFERON ALPHA TEST
Addition of I125 labelled 
monoclonal to IFN-a
Incubate at room 
temperature for 
V 2 hours
Addition of solid phase 
with covalently coupled 
sheep anti-IFN
Vigorous agitation at 
room temperature 
t for 2 hours
Addition of pre-wash buffer®
Leave for 5 minutes 
undisturbed
Sucrose separation (gravity dependent^
Leave for 15 minutes 
undisturbed
Aspirate supernatant
f
Repeat steps 1 & 2
Count radioactivity of solid 
phase in gammacounter
Extrapolate test count on standard 
curve for IFN-a level
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The specimens tested were clarified samples ie. serum, NPA at a 
dilution of 1:10 in VTM, CSF and urine.
The test procedure was carried out at room temperature in an area 
designated for radioactive work. The specimen (200yMl) was incubated for 
two hours with the radiolabelled monoclonal antibody to IFN- o( (50^1). 
The polyclonal anti IFN- d  coupled to the solid phase (50yul) was added 
to the specimen/monoclonal antibody complex and further incubated for 
two hours on an orbital agitator at 300-350 rpm.
The complex was washed in prewash buffer (1ml) and allowed to settle 
for 5 minutes. The manufacturers "Sucropette" was placed in the tubes 
in the correct orientation and "Sucrosep" (2mls) added to the wells.
The "Sucrosep" was allowed to drain through the "Sucropette" and the 
solution settled for 15 minutes. The top layer of unbound particles 
(green phase) was aspirated leaving 0.3 mis in the bottom of the tubes. 
The wash step was repeated once more. The radioactive level was 
measured using an LKB Beckman gamma scintillation counter.
A series of standard IFN- c< preparations were placed, in duplicate 
through the IRMA, see section 3.1.3. The counts per minute (cpm) were 
plotted against the standard IFN-concentrations. The radioactive 
level in the specimens was calculated by extrapolation of the counts 
per minute against the standard preparations. The levels of IFN- o( 
were expressed as International units per millilitre (IU/ml).
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2.1.9 INDIRECT IMMUNOPEROXIDASE TECHNIQUE
An indirect immunoperoxidase technique (Foulis et al., 1987) specific 
for the measurement of IFN-<?< in tissue specimens was performed within 
the Pathology Department, Glasgow Royal Infirmary.
Formalin processed paraffin sections of the six levels of lung prepared 
post autopsy were cut using a microtome (4 pm) and placed on subbed 
slides (3-aminopropyltriethoxysilane coated) and placed through an 
in situ technique specific for the detection of IFN- of . The IFN- of 
antibody (H51) raised in sheep was obtained from Dr A. Meager, National 
Institute of Biological Standards and Control (NIBSC), London. The 
sheep anti IFN- of was raised using human lymphoblastoid IFN- of (HU 
IFN-o<Ly Namalwa Wellferon) as antigen. The antibody and normal sheep 
serum purified to minimise non specific binding by absorbing onto liver 
powders (guinea pig and porcine) and were thoroughly washed prior to 
the addition of antibody.
The sections were taken down to water through a series of alcohols, 
washed in tris saline (pH 7.5) for 10 minutes then endogenous 
peroxidase blocked by placing the sections in rrethanol/H202 /HC1 for 30 
minutes. The slides were transferred to tris saline for a further 10 
minute wash. The slides were blotted dry and the normal swine serum 
(NSS, 1:5 in tris buffer) placed on the sections for 15 minutes to 
reduce background staining. Excess NSS was removed and interferon- of
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activity (1:100) added to the relevant sections.
The tissue sections were incubated overnight at 4 °C. Twenty four 
hours later the slides were washed in tris saline for 10 minutes, 
blotted dry and NSS (1:5 diluted in tris buffer) aliquoted using a 
capillary dropper onto the sections for 15 minutes. The secondary 
antibody, swine anti-sheep horse radish peroxidase (SWASH-HRP, 1:200) 
was added for 30 minutes. The slides were washed in tris saline and 
then placed in 3,3' diaminobenzidine (DAB) for 10 minutes. The sections 
were placed in counterstain-haematoxylin for 30 seconds, dehydrated and 
mounted for microscopic examination. The number of positive cells per 
five high power fields were counted. The high power field was 
calculated as 1400 square microns.
A negative control slide of normal sheep serum was run in parallel with 
the IFN-^ sections. Controls to check the specificity of the IFN- 
antibody were carried out using antiserum IFN- oC (H51) incubated with 
Wellferon Hu IFN- o( at 4 °C overnight. Staining of sections with was 
compared with absorbed anti sera and the IFN- sera diluted in tris 
saline.
2.1.10 DETECTION OF MACROPHAGE CEDE. POPULATION USING MONOCLONAL 
ANTIBODY( KP 1)
The macrophage cell population in the lung sections was identified 
using a monoclonal antibody specific for macrophage/histiocytes in an
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immunocytochemical technique, (Pulford et al., 1989).
The lung sections were placed through a series of alcohols, 
rehydrated to water then washed in tris saline for 10 minutes.
Endogenous peroxidase was blocked by placing the slides in 
methanol/Hz02/HC1 for 30 minutes at room temperature. The sections were 
washed in tris saline. They were then trypsinised for 20 minutes at 
37 ° C, the wash step was repeated, primary antibody, monoclonal 
antibody KP1 at a dilution of 1:20 placed over the sections and the 
slides incubated at 4 °C overnight.
The antibody was blotted and the sections washed in tris saline for 10 
minutes. The secondary antibody: rabbit anti mouse horse radish 
peroxidase, (RAM-HRP, 1:50) was placed on the sections and incubated at 
room temperature for 30 minutes. The sections were washed in tris 
saline, placed in DAB for 10 minutes and counterstained in haematoxylin 
for 30 seconds. The sections were hydrated, mounted and examined for 
intracytoplasmic specific brown staining by light microscopy to 
determine the number of positive cells. The cells were counted per 
high power field (x40) which was defined as 1400 square microns.
STATISTICAL METHODS
The statistical methods for the non-parametric data analysed in 
I this thesis included the Mann Whitney U-test and the Wilcoxon
Rank Sum test.
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CHAPTER 3
3.1 EXPERIMENTAL DATA SECTION
3.1.1 EVALUATION OF NEGATIVE CONTROL STANDARDS FOR SERUM AND VTM
Negative control standards as the serum diluent (0 IU/ml IFN- <*) and 
VIM (0 IU/ml IFN- oC ) were aliquoted (200 ul) into ten labelled tubes 
and tested for endogenous alpha interferon using the "Sucrosep IFN-c*", 
IRMA, see section 2.1.8. The mean value for total counts and standard 
deviation were calculated.
Results
The number of counts, standard deviation and coefficient of variation 
for the serum and VTM samples are indicated in Table 3. The mean 
values were 75 and 120 cpm for serum and VTM, respectively. The 
coefficient of variation was <10% for VTM samples and 10.6% when 
calculated for serum diluent. Only VTM was found to have an acceptable 
intra-assay reproducibility.
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TABLE 3
Negative Control Standards 
(0 ID/ml IFN- ) Assayed in 
Serum and VIM Diluent using 
Sucrosep IFN- "IRMA"
DILUENT
Sample Serum (cpm) VIM (cpm)
1 75 104
2 70 110
3 84 121
4 69 132
5 85 125
6 70 120
7 83 131
8 60 124
9 75 113
10 80 119
Serum VIM
Mean 75 120
Standard Deviation (SD) 8-0 8.9
Coefficient of Variation (%) 10.6 7.4
72
3.1 .2 EVALUATION OF THE IFN- C< STANDARD CURVE IN SERUM AND VIM 
DILUENT
A series of IFN- o( standard concentrations (0, 1, 4, 16, 64, 256, 1024 
IU/ml) were prepared from the standard IFN- oC preparation (1024 IU/ml 
IFN- cX. ) (MRC 69/19 International Reference Preparation for the 
calibration of human leucocyte IFN-cX) in serum and VTM. Each standard 
preparation was assayed in duplicate (200 p.1) in the "Sucrosep IFN- c< 11 
IRMA, see section 2.1.8 and a radioactive signal finally measured as a 
quantitative measure of interferon found i.e. analysis of the counts 
per minute (cpm) obtained from the radiolabelled IFN- oi monoclonal 
antibody reactive in the assay against the IFN- oC standard 
concentration plotted on log/log paper. A standard curve was drawn 
through the points. A standard curve of the different IFN- ex' 
concentrations was prepared on the arrival of the new batch reagents 
every six weeks.
Throughout the study, the reproducibility of the standard curve was 
analysed by calculating the mean values for ten individual assays, of 
each standard concentration, in duplicate, from both serum and VIM 
curves. These values were plotted and the best fit line through the 
points analysed by regression analysis. The standard deviation, 
standard error and coefficient of variation were also calculated.
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Results
The best fit line through the levels calculated for various IFN- 
concentrations using the "Sucrosep IFN- oi 11 IRMA in serum diluent is 
shown in figure 2 and for VIM in figure 3. The coefficient of 
variation is >10% in both sets of results but the levels in these 
interassay studies were within expected values for VTM (ie.11-20%) and 
within acceptable limits for serum (i.e.21-30%) (Tables 4 and 5).
3.1 .3 MINIMUM DETECTION LIMITS IN BODY FLUIDS: NPA, SERUM AND CSF 
USING THE "SUCROSEP IFN- 11 IRMA
The minimum detection limits for the measurement of IFN- oC in body 
fluids using the "Sucrosep IFN- 11 IRMA were evaluated within this 
laboratory, Virology Laboratory, RHSC, Glasgow in previously published 
studies. Since IFN- o( tests under the same conditions and 
standardisation are currently in place at the Virology Laboratory,
RHSC, it was thought appropriate to utilise this information and use 
the cut off levels predetermined for NPA, serum and CSF, in the cot 
death study.
Ho Yen and Carrington (1987) investigated the usefulness of IFN- ci 
levels in CSF as an indicator of cases of viral meningitis as opposed 
to bacterial meningitis and determined levels of >1.5 IU/ml in CSF and 
serum to be of significance in clinical practice / however at this time a
| neutralisation blocking step was not included to confirm the 
specificity of interferon detected.
SERUM STANDARD CURVE OVER 10 ASSAYS USING 
"SUCROSEP IFN-cc" IRMA
cpm
100,000
10.000“
1,000-
100-
256
U/ml IFN
Figure 2
VTM STANDARD CURVE FOR IFNcc VALUES (Q-256U/mI) OVER 
10 CONSECUTIVE ASSAYS USING ’’SUCROSEP IFN-cc" IRMA
cpm
10,000-
1000-
100-
256
U/ml IFN
Figure 3
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TABLE 4
Statistical Analysis of a Series of IFN- o< 
Standard Levels (0-256 IU/ml) in Serum Diluent 
Measured by "Sucrosep IFN- oC " IRMA
IU/ml
IFN-cX
Mean
(cpm) S.D. S.E. C.V. (%)
0 75 17 5.5 23
1 130 25 8.06 19.6
4 257 30 9.68 21.8
16 687.9 70 22.4 19
64 2561.7 573 181.5 22
256 8839 1717 542.8 19
S.D. = Standard Deviation
S.E. = Standard Error
C.V. = Coefficient of Variation
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TABLE 5
Statistical Analysis of a Series of IFN-o< 
Standard Levels (0-256 IU/ml) in VTM Measured by 
"Sucrosep IFN- c* " IRMA
IU/ml 
IFN- oC
Mean
(cpm) S.D. S.E. C.V. (%)
0 118.7 21.8 2 18
1 160 25.9 2 16
4 323.8 41.6 4 13
16 822 96.1 9 11
64 2972 362.7 36 12
256 \ 9417.7 1134 113 12
S.D. = Standard Deviation
S.E. = Standard Error
C.V. = Coefficient of Variation
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Salas M.P. (Glasgow University MSc Thesis 1988) investigated the IFN- 
values measured in nasopharyngeal secretions (NPS) during an RSV 
epidemic. The specimen used was at a dilution of 1:10 in VIM and she 
observed that the level at which endogenous IFN- oC could be 
neutralised was 0.2 IU/ml i.e. 2 IU/ml (undiluted specimens).
3.1 .4. NEUTRALISED VALUES OF IFN- STANDARDS FOR BOTH SERUM AND 
VIM DILUENT
In order to test the specificity of the IRMA technique, the IFN- 
present in the standards/specimens was neutralised/blocked in a 
competitive assay by incubating with an excess of polyclonal sheep anti 
IFN- oC prior to re-evaluation in the IRMA.
Method
IFN-oC standard preparations (0, 1, 4, 16, 64, 256, 1024 IU/ml) and 
samples in duplicate aliquots of 200 ^ il were placed in labelled tubes. 
50 pi of the polyclonal sheep anti IFN- oc coupled to a solid phase 
(sepharose) was added to one of the labelled tubes. The 
standards/specimens were agitated on an orbital shaker for 2 hours at 
roan temperature. The standards/specimens were centrifuged at 4000g 
for 20 minutes and the supernatant assayed for residual IFN- activity 
as in section 2.1.8. The neutralised standards/specimens were assayed 
in parallel with the control standards/specimens placed in the second
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labelled tube.
Results
The cpm of 1251 versus the standard concentrations (0, 1, 4, 16, 64, 
256,1024 IU/ml) of the neutralised and control (unneutralised) are 
plotted on the graphs in figures 4 and 5 for both serum and VTM
diluents. The formula to denote the % IFN- oi activity was:
% IFN- oi activity =
(Unneutralised value-Neutralised value)-Background reactivity x 100 
Unneutralised value - Background reactivity
The neutralised/blocked values of standard preparations are noted in 
Table 6. One hundred per cent of the IFN- o( activity was 
neutralised/blocked in the 0, 1, 4, 16, IU/ml standard preparations 
diluted in the serum solution and found to be neutralised/blocked to 
100% in VTM. Residual IFN- activity of the order of 3%, 6% and 8%
remained in the 64, 256 and 1024 IU/ml IFN- standards in serum. Two
per cent residual IFN- o( activity remained in the 64 and 256 IU/ml IFN- oC 
standard diluted in VTM. Six per cent IFN- o( activity remained in the 
1024 IU/ml IFN- oi standard diluted in VTM. Hie implication was that in 
a standard preparation of 1024 IU/ml IFN- ^  90 - 93% of the binding 
activity measured was specific for IFN- oC .
NEUTRALISED / BLOCKED IFN-oc STANDARD PREPARATIONS
IN SERUM DILUENT USING MSUCROSEP IFN-oc" IRMA
cpm
1,000 -
neutralised
100 -
0.1 256641 16
U/ml IFN
Figure 4
NEUTRALISED / BLOCKED IFN-oc STANDARD PREPARATIONS
IN VTM USING ’’SUCROSEP IFN-oc" IRMA
cpm
100,000
10.0001
1.0001
neutralised
-o-
100H
256
*
U/ml IFN
Figure 5
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TABLE 6
Naital iised/blocked Values cf Stancbrd IEN- c<Enq^ rafcicns in Seam and V M  Diluent 
Using ’‘Suaoeqp HN-£<11 IEMA
Xbtj- oC
IU/ml
Starrbrd qan
Seam
Eesicbal IBN-^ 
Activity IU/ml
(%)
blocked qan
V M
ResidBl IEN-<X 
Activity 3U/ml
(%)
blocked
0 70 0 100 120 0 100
1 125 0 100 160 0 100
4 225 0 100 285 0 100
16 615 0 100 750 0 100
64 2560 88 97 2566 65 98
256 8400 560 94 9745 240 98
1024 12200 980 92 14405 840 94
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3.1.5 NEUTRALISATION OF IFN- ACTIVITY IN (XT DEATH SPECIMENS AND CSF 
SAMPLES FROM PAEDIATRIC AND ADULT DEATHS
Dae to the small quantities of specimen available for testing only a 
limited number of the samples (NPA, serum and CSF) could be analysed in 
order to indicate that the IFN- measured by the IRMA technique was 
not artef actual.
Method
The level of IFN- oL was measured in the specimens after the additional 
neutralised/blocking step was carried out as in section 3.1.3. An 
aliquot of the original sample was evaluated in parallel with the 
neutralised specimen. The samples investigated had IFN- levels 
measured by IRMA ^ 1.5 IU/ml for serum and ^ 0.5 IU/ml for CSF.
Results
Samples with sufficient quantity of material for further evaluation 
included 50 NPA samples, 45 serum samples and 24 CSF samples from cot 
death cases. Samples from paediatric deaths included 10 NPA 
specimens, 8 serum specimens and 10 CSF samples. A group of adult 
deaths (22 CSF specimens, mean IFN- value 1.94 IU/ml) were 
evaluated in parallel with the cot deaths specimens. The specimens 
analysed are shown in Tables 7 and 8.
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THESE 7
Neutalisafcim  c f U N - A ctivity jyfeasuned in  NEa and Ssnm in  
Q ± Etotis and Ebadiabdc Doatiis
Chsas
M uter 
c f Chses
M uter 
c f IFN- c* 
tested (%)
M uter >50% 
reductim  in  
UN- oC (%)
NEa
Gbt deaths 97 50 (52) 45/50 (90)
Baediatric deaths 24 10 (42) 9/10 (90)
SEEOA
Gbt deaths 99 45 (45) 44/45 (97)
Ebediatric deaths 25 8 (32) 7/8 (87)
TABLE 8
Neutralisation of IFN- ot Activity Measured in CSF Samples from 
Cot Death Cases, Paediatric Deaths and Adult Deaths
Cases
Total 
Number 
of Cases
Number of 
IFN- oi Tested 
>0.5 IU/ml (%)•
Number
>50%
redn IFN-<*. (%)
Cot deaths 99 24 (24) 24/24 (100)
Paediatric deaths 26 10 (38) 8/10 ( 80)
Adult deaths 22 22 (100) 18/22 ( 81)
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The samples of serum and CSF from cot death cases when tested indicated 
that between 97-100% of the samples could be reduced 50% in IFN- oC 
value after neutralisation/blocking experimentation. The paediatric 
death samples of serum and CSF and also the CSF samples from adult 
deaths showed similar numbers of cases with a significant reduction in 
IFN- oC level (80%). In 5 cases the NPA samples from cot death cases 
showed residual IFN- o< activity in post neutralisation/blocking tests. 
The IFN- oC values on initial testing suggested levels of >16 IU/ml 
which were finally shown to have 10% IFN- oC activity i.e. 1.6 IU/ml in 
sample (as analysed earlier for standard preparation, see section 
3.1.4).
Although cases were seen in paediatric and adult deaths where false 
positive interferon levels were recorded when compared with cot death 
data (Table 8)^  no significant difference was found i.e. there was no 
greater tendency for false positives to occur in any age group.
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In order to evaluate the sensitivity and specificity of the "Sucrosep 
IFN- oC 11 irma in the clinical situation, studies were carried out to 
determine the level of IFN- oi present in serum samples.
3.1 .6 INVESTIGATION OF SERUM IFN- IN PAEDIATRIC PATIENTS
A group of 53 serum samples obtained from paediatric patients (29 
females: 24 males, mean age 5 years) with no suspected infectious 
illness were obtained from the RHSC, Glasgow blood bank. The specimens 
were evaluated for the presence of IFN- oC using the Sucrosep IFN- ^
IRMA as demonstrated in section 2.1.8. Labelled tubes for background 
reading, total count and a control standard of 4 IU/ml IFN- o( were 
analysed in the assay run.
Results
The levels of IFN- o( present in serum are illustrated in Table 9.
Five sera, representing 9% of the total number of samples, gave 
detectable levels of IFN- above the minimum detection limit set at
1.5 IU/ml (see section 3.1.3). The mean level of IFN- oC present in 
positive samples was 2.9 IU/ml. The mean level of total samples was 
0.5 IU/ml IFN- oC .
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TABLE 9
Serum U N -  oC in 
Paediatric Patients, 
RHSC, Glasgow
Cases
U N -  ot Level 
(IU/ml) Cases
UN- oC Level 
(IU/ml)
1 1.5 6-32 0
2 2.0 34 0.2
3 2.0 35-38 0.3
4 3.2 39-40 0.4
5 6.0 41-43 0.5
44-45 0.6
46-47 0.8
48-49 1.0
50-53 1.1
Mean 2.9
Mean of
Total
Samples 0.5
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CHAPTER 4
4.1 CONCLUSIONS OF THE EXPERIMENTAL SECTION
Published data on the sensitivity and specificity of IFN- oC immunoassays 
has been analysed with particular reference to the clinical situation 
and samples taken (Parry & Parry, 1981, Taylor et al., 1985). As part 
of this study, it has been important to evaluate the IRMA immunoassay 
used here to verify the presence of alpha interferon in specimens 
received from the cot death post mortem cases.
The assay was carried out in a supervised radiation area approved by 
the Radiation Protection Officer and safety standards met the 
International Committee on Radiation Protection (ICRP) code of 
practice. Particular care was taken with monitoring the radioactive 
area and records kept of the isotope received and used. The diagnostic 
reagents arrived every six weeks, one week after radiolabelling of the 
monoclonal antibody with 1251. Due to the half life of 1251 (i.e. 59.6 
days), the test reagents had a short shelf life.
The standard preparations were aliguoted in 300 jul quantities and 
stored at -70GC. Specimens prepared for assay were also aliquoted and 
stored at -20°C or -70°C depending on the length of time until testing. 
Thawing and refreezing of samples was avoided as the IFN- oC activity 
decreased over a period of time.
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The NPA samples were diluted in viral transport medium in order to 
obtain sufficient specimen for assay in the IRMA test. As NPA samples 
contained mucous material and CSF samples were occasionally 
bloodstained these specimens werecentrifugedprior to testing as sample 
debris was occasionally associated with false positive results.
The within or inter assay capability of the assay was tested on ten 
sequential samples of neat {0 IU/ml IFN-oQ in serum diluent and VTM 
see Table 3. The coefficient of variation for serum diluent was 10.6% 
and for VTM diluent 7.5%. Using the same assay system Chard and 
co-workers (1986) and Ho Yen and Carrington (1987) detected a 
coefficient of variation of 4.2% and <10%, respectively for a series 
of samples of serum diluent analysed in the same assay on the same day. 
The results obtained in this study were therefore considered compatible 
with other data.
The between or intra assay reproducibility was tested over ten 
consecutive standard curves. Any variation between each reagent batch 
was not statistically significant. On receipt of the new diagnostic 
reagents, the standard preparations were assayed in duplicate for each 
diluent. Chard (1986) again noted low variability between assays of 
6% when using serum as diluent. The results from this study 
demonstrated acceptable limits during intra and interassay 
reproducibility- sufficient to believe that over the two year study 
period the assay performed reliably.
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Further experimentation to detect the specificity of the "Sucrosep 
IFN- 11 IRMA, was carried out in the study. Although a monoclonal 
antibody specific to IFN- oi (Yok 5/19) was incorporated in the assay 
system, the ability of the monoclonal antibody to detect IFN- <X was 
investigated using a neutralisation/blocking technique. The 
term neutralisation/blocking is used in the thesis to describe the extra 
experimental step carried out prior to the IRMA testing.
The assay utilises excess polyclonal anti-IFN- to react with 
the IFN- o( sites available on the samples hence the test does not adhere 
to a virological definition of neutralisation in an infectivity sense, 
but rather a blocking of the free IFN- oC antigen sites on the 
standards and samples.
Results indicated that the recombinant IFN- c* (standard preparation MRC 
69/19) was completely neutralised/blocked (100% removed) in standards 
up to 16 IU/ml and almost completely blocked (90% removed) in samples 
up to 1000 IU/ml (Figures 4 and 5, Table 6) in both serum and VTM 
diluents. Analysis of the clinical samples, NPA, serum and CSF 
using the additional competitive step in the assay, prior to testing for 
IFN- oC confirmed the specificity of the test to detect 
'non artefactual1 IFN- o( (Tables 7 and 8). The number of cot death 
specimens analysed in this way were limited due to the small quantity 
of samples available from post mortem. Salas (1987) indicated similar 
results by using the neutralisation/blocking assay prior to IRMA 
analysis of endogenous IFN- oC in NPA specimens in VTM obtained during
an RSV epidemic and confirmed excellent specificity in the test.
Studies of the recombinant monoclonal antibody to IFN- <X (Yok 5/19) 
have shown the ability of this monoclonal antibody to detect at least 
seven subtypes of IFN- (X A (2), C, D (1), G (5), I, J (7) and K (6), 
although more than 24 species of IFN- oC are known. However a number 
of IFN- <X subtypes may be missed in clinical specimens evaluated in 
this IRMA.
The evaluation of IFN- cL levels in the cot death situation required 
knowledge of IFN- <X values present in specimens received from children 
who had no clinical evidence of viral disease. For ethical reasons, 
it was not possible to analyse samples from infants in the community 
setting therefore samples of serum from the hospital blood bank were 
thought to represent a reasonable group of serum samples from age 
matched infants. Children admitted for general surgery were chosen in 
this study. The results from normal children in the present study 
indicated that 9% of serum samples assayed had detectable levels of 
IFN- oC (Table 9). This detection rate from an infant population 
was similar in number to the 6% of serum samples also with detectable 
levels of IFN- X noted by Chard in a similar study using the "Sucrosep 
IFN- oL " IRMA. The IFN- levels were detected at a low level in these 
specimens however their presence was above the cut off level and 
considered positive for IFN- oC .
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It is a widely held view that IFN is not normally found in the serum from 
healthy individuals, however researchers have used biological assay to 
identify leucocyte IFN- (Green et al.,1982, Chisholm & Cartwright, 
1987) and the ability to detect levels of IFN- o(. <10 IU/ml was
questionable. The increased sensitivity of the assay i.e. ^1 IU/ml 
used may explain the interferon yield in this study.
The IRMA used in the study shewed high sensitivity and specificity to 
IFN- oC . Large numbers of samples could be evaluated rapidly and the 
results obtained within twenty four hours of receipt of specimen.
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CHAPTER 5
ANALYSIS OF TEE EPIDHVIIOLOGICAL FEATURES ASSOCIATED WITH COT DEATHS 
PART 1
Glasgow Data
During the study period, January 1987 to March 1989, brief clinical 
histories from one hundred suspected cases of cot death referred from 
the Procurator Fiscal Office, Glasgow were collected and analysed.
Although data was obtained from the post mortem reports and other 
sources e.g. parent interviews, police reports in many cases this was 
incomplete.
5.1 .1 GEOGRAPHICAL LOCATION OF COT DEATH CASES
The hone address and place of death of the cases referred to the 
Pathology Department, RHSC were principally from within the Glasgow 
City boundary, see figure 6. The number of cases indicated on the map 
was 73 (73%) of the total cases analysed as documented in Table 10.
The remaining cases were located in Airdrie/Coatbridge (7), Paisley (5), 
Bridge of Weir (2), Holytown (1), Drumry (1), Spittal (1), Wishaw (1) 
and Argyll (3), Table 11. The areas with highest numbers of cot death 
cases are denoted by the heavily shaded/black areas on the map:
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TABLE 10
Distribution of Cot Death Cases by Postcode Area, Glasgow
Post Code Areas
Number 
of Cases
G4 Townhead 1
G13 Kelvindale 2
G14 Knightswood 1
G15 Drumchapel 2
G20 Maryhill 6
G21 Woodlands 3
G22 N. Kelvinside/High Dossil 3
G31 Parkhead 2
G32 Camtyne/Shettleston 1
G33 Blackhill/Riddrie/Ruchazie 6
G34 Easterhouse 7
G40 Bridgeton/Dalmarnock 3
G41 Dumbreck/Pollockshields 2
G42 Toryglen 3
G43 Pollockshaws/Newlands 2
G45 Castlemilk 3
G46 Giffnock/Thomliebank 2
G51 Ibrox/Govan 2
G52 Penilee/Cardonald 2
G53 Pollock/Nitshi11 3
G62 Milngavie 1
G64 Bishopbriggs 1
G66 Kirkintilloch 2
G67 Cumbernauld 1
G69 Baillieston 1
G73 Rutherglen 1
G75 East Kilbride 1
G81 Clydebank 4
G82 Dumbarton 2
G83 Alexandria 1
G84 Helensburgh 2
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TABLE 11
Distribution of Cot Death Cases Outwith 
Postcode Area, Glasgow
Area No. of Cases
Airdrie/Coatbridge 7
Drumry 1
Paisley 5
Spittal 1
Holytown 1
Bellshill 1
Bridge of Weir 2
Argyll 3
Hamilton 2
Motherwell 1
Wishaw 1
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G20 Maryhill (6), G33 Blackhill (6), G34 Easterhouse (7),
Airdrie/Coatbridge (7) and Paisley (5). The figure in the brackets 
represented the percentage of total cases. The location of the cot 
death cases follows a concentric pattern around the city centre similar 
in appearance to the location of the main housing areas of the city.
5.1.2 MONTHLY DISTRIBUTION OF COT DEATH CASES
The monthly distribution of the 100 cases examined during the study 
period is represented on the bar chart in figure 7. For each year 
i.e. 36 in 1987, 42 in 1988 and 22 in the early months of 1989, the 
highest distribution of cases was found to be between January and April 
each year (1987, 1988, 1989) at 17%, 18% and 20%, respectively. A 
lower percentage of cases was noted between May to August for each year 
studied i.e. 5% and 10%, and the month with the lowest number of cases 
was June, in both years. Although the data is limited, to a two year 
analysis, it would support a June and October low with January and 
September peaks in a twice yearly cycle.
The number of respiratory virus infections reported to the
Cormunicable Diseases Unit, Ruchill Hospital, Glasgow each month
during the study period from the Glasgow Virology Laboratories were
numerically analysed and plotted on a graph beside the number of cot
death cases as in figures 8a and 8b. A similar pattern of presentation each
month was noted with highest numbers of cases detected during the
winter months.
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5.1.3 AGE DISTRIBUTION OF GOT DEATH CASES
The mean age of the one hundred suspected cot death cases was 
calculated as 16.6 weeks from within the age range 17 days and 53 
weeks.
Analysis of the age distribution is tabulated in Table 12 . Twenty 
three infants were aged 1-18 weeks, 39 infants were 9-16 weeks of age, 
22 infants were aged 17-26 weeks and 16 infants in the 27-53 week age 
group i.e. the age range with highest incidence of cot death in this 
study was in infants between 2-4 months of age, with 62% of deaths in 
the first 6 months of the year. The mean age of paediatric deaths (non 
cot death) in this study was 1.4 years.
5.1.4 DETAILS RELATING TO SIBLINGS
The position of the cot death victim in relation to other infants in 
the family unit was analysed. The results are shown on Table 13.
Eight infants were from twin births and one infant was from a set of 
triplets. Thirty eight infants were shown to be the only child in the 
family group. Eighteen cases had one additional infant in the family. 
Fifteen cases had two additional infants and sixteen families had 3 
additional infants in the family. In summary 58 cot deaths occurred in
t
families where other siblings were present compared to 38 as the only 
child.
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TABLE 12
Age Distribution of Cot Death 
Cases, RHSC, Glasgow
Age Range 
(weeks)
No. of Cases
1-18 23
9-16 39
17-26 22
27-53 16
(
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TABLE 13
Position of Cot Death Victim in 
Family Unit
No. of Infants 
in Household
No. of
Cot Death Cases
0 (only child) 38
1 18
2 15
3+ 16
Twin 8
Triplet 1
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5.1 .5 niWESS PRIOR TO DEATH IN GOT DEATH CASES
Fourteen cases (14%) were admitted to hospital for a period of time but 
all the infants were discharged and at home prior to death. The 
infants were referred to a hospital paediatric unit for a variety of 
disorders including bronchitis, suspected meningitis, acute renal 
failure, stenosis and hole in the heart. The number of infants 
admitted to hospital with respiratory disorders was calculated as seven 
infants (50%) of the infants with recorded stay in hospital. These 
included infants with upper and lower respiratory tract infection.
Details of the illness were fairly limited as the histories were taken 
shortly after the death of the infant.
The remaining infants in the study not hospitalised prior to death were • 
86 cases. Seventy nine cases had informative clinical histories and no 
evidence of serious illness. There were, therefore, seven infants from 
the total eighty six cases with no clinical details available due to 
their location outwith the city boundary.
However, a total of36/93(39%)infants had history of respiratory 
infection, cold, cough, congested, snuffly and 4/93(4%); infants 
presented with diarrhoea and vomiting a few days before death. Hence, 
the total number of infants with illness prior to death was 54/93(58%)*
The number of infants with no obvious signs of illness was 39/93(42%),
All of the infants attended the baby clinics after birth.
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The paediatric deaths were all brought to the Pathology Department from 
the hospital wards. The largest group (12/27) were cardiac cases who died 
less than 10 days after surgery.
5.1.6 DETAILS OF VACCINATION
The number of cases in the study group eligible for first triple 
vaccine to diphtheria, tetanus and pertussis (DTP) and oral polio 
vaccine came to a total of 52/93(56%) (The clinical histories were 
examined on the 93 cases with clinical details and 28/52 (54%)sases had 
received vaccination. From the 65 retraining, a total of 24 (37%) cases 
were unprotected. However, 12 cases out of the 65 had no record of 
vaccination. One case had details from the general practitioner (GP) 
advising against vaccination at the appropriate age due to ill health 
of the infant. This left 29 cases not eligible for vaccination.
99
PART 2
Edinburgh Cases
The relevant information for a limited epidemiological study on the 
ninety eight suspected cot death cases brought to the Pathology 
Department, RHSC, Edinburgh was collected. Specimens for IFN- o< assay 
from these cases were sent to Glasgow during the period March 1987 to 
June 1989.
5.2.1 GEOGRAPHICAL LOCATION OF COT DEATH CASES
The largest proportion of suspected cot death cases (64) brought to the 
Pathology Department, RHSC, Edinburgh were from within the Edinburgh 
city limit, see map in figure 9. The RHSC Department, Edinburgh was 
the main East coast centre for post mortem analysis of sudden death in 
infants ( <1 year) hence cases were also brought for autopsy from Fife 
(27) and the Borders (7), Tables 14 and 15.
The hatched and solid black areas on the map are those with higher 
numbers of cot death cases and includes segments of the city denoted by 
post code areas EH14, Balemo/Currie/Riccarton (6),
EH4, Silverknowes/Clermiston (5), EH6, Leith (4). There was also an 
area in Fife district which had an increased number of cot deaths 
i.e. 8 deaths (8%) during the study period.
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TABLE 14
Distribution of Cot Death Cases by- 
Edinburgh Postcode Areas
Postcode Areas
Number 
of Cases
EH4 Silverknowes/Clermiston 5
EH6 Leith 4
EH7 Abbeyhill 3
EH8 Pleasance 1
EH9 Southside 1
EH10 Momingside 1
EH11 Polwarth/Sighthill 4
EH12 Murrayfield 1
EH13 Collington 1
EH14 Balerno/Currie/Riccarton 4
EH15 Portobello 3
EH16 i Liberton 6
EH17 Gilmorton 1
EH19 Bonnycraig 2
EH20 Musselburgh 3
EH22 Dalkeith 2
EH23 Gorebridge 1
EH26 Penicuik 3
EH28 Newbridge 2
EH29 South Queensferry 1
EH32 Longniddry 1
EH41 Haddington 1
EH42 Dunbar 1
EH47 Whitburn 3
EH48 Bathgate 3
EH49 Linlithgow 1
EH53 East Calder 1
EH54 Livingston 3
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TABLE 15
Analysis of Cot Death Cases Outwith 
Edinburgh City Boundary
Postcode/Area Number of Cases
Borders
TD1 2
TD5 1
TD7 Galashiels 2
TD13 1
TD14 1
Fife
KY1 3
KY2 4
KY4 3
KY6 3
KY7 3
KY11 8
KY12 3
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The distribution of cot deaths in the postcode areas of the city again 
follow a similar pattern to that of the geographical location of 
housing estates radiating from the city centre.
5.2.2 MONTHLY DISTRIBUTION OF GOT DEATH CASES
The distribution of cases by month is presented on the graph in 
figure 10. A trend was noted in the number of infants dying each year: 
36% of total infants in study in 1987, 40% in 1988 and 24% in the early 
part of 1989. When the year was separated into four monthly parts a 
pattern of the number of infants dying during each year emerged.
During January to April for 1988 and 1989 15% and 20% of cases were 
brought for post mortem. The study started in March 1987 hence only 5% 
of infants died during March and April of that year. Lower percentages 
were observed in the "Summer" months - May to August during 1987 and 
1988 as shown by the following figures, 10% and 9%. The study ended in 
June 1989 hence only 4% of cases were noted for May to June 1989.
During the latter part of the year, September to December in 1987 22% 
of cases were collected and 16% in 1988.
The number of cot death cases and the number of respiratory virus 
infections reported to the Communicable Diseases Unit at Ruchill 
Hospital , Glasgow from the Edinburgh Virus Laboratories throughout 
the study were analysed as shown in figures 11a and 11b. Although cot 
death numbers are low, the winter excess was coincident with the winter 
increases of respiratory virus infections reported.
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5.2.3 AGE DISTRIBUTION OF COT DEATH CASES
The mean age distribution of the Edinburgh cot death cases was 21 weeks 
as calculated from the age range 1 week to 124 weeks (Table 16).
Nine cases from the group were found >52 (range 64 weeks to 124 weeks) 
weeks and hence did not conform to the standard categorisation of cot 
death infant i.e. <1year, however the data was collated on these 
infants. The details therefore have been included in the thesis with 
particular note to the different age range. Analysis of the cases 
showed that 18 infants were in the low age range of 1-8 weeks, 34 
infants were in the 9-16 week group, 21 infants in the 17-26 week age 
range, 16 infants in the 27-52 weeks age group and 9 infants > 52 weeks 
of age. The age range with highest numbers of cot deaths was the 9-16 
week group. The number of infants dying aged 1-16 weeks was 52 (53%) 
and in the upper age range 17-52 weeks, 46 cases (47%).
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TABLE 16
Age Distribution of Cot 
Death Cases, Edinburgh
Age Range 
(weeks) No. of Cases
1-8 18
9-16 34
17-26 21
27-52 16
>52 9
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CHAPTER 6
6.1 CONCLUSION OF THE DEMOGRAPHIC STUDY
Two major Scottish centres, Glasgow and Edinburgh covering 2.5 million 
people out of a total population of 5 million represented a substantial 
study population. The study group of 198 cot death cases were thus 
representative of a large population group. It was appropriate to 
include a limited epidemiological analysis of the clinical and 
environmental results. Epidemiological studies of cot death data over 
the past fifteen years has enabled "risk" groups of infants to be 
identified within the community (reviewed by Peterson, 1984). The 
collection of data from this multi-centre study resulted in detailed 
information related to social and clinical aspects of both 
Glasgow and Edinburgh | cot death cases ,
The geographical location of cot death cases throughout the two 
Scottish cities (Figures 6 and 9; Glasgow and Edinburgh) included in the 
study, showed a similar distribution pattern. Higher numbers of cot 
death cases were indicated in several postcode areas in Glasgow 
the location of which were in densely populated housing schemes, 
(Easterhouse, Blackhill, Castlemilk, Paisley, Airdrie and Coatbridge).
A number of these post code areas, (G33, G34) were identified as having 
housing of low grade as defined by Greater Glasgow Health Board, 1986. 
The numbers of cot death cases in Edinburgh in the postcode areas were 
spread out throughout the city. Higher numbers were noted in areas such
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as Silverknowes/Clermiston, Balerno/Currie and also Sighthill (Table 14).
Other factors of social deprivation were not analysed in the study, 
hence no conclusions were recorded concerning the social conditions of 
the families in the survey. It was noted by Emery and colleagues that 
in order to draw conclusions concerning the social status of the families 
in the cot death group required a set of parameters prior to initiation 
of the study.
As both city and rural areas were investigated in the study it was noted 
that the largest number of cot death cases were found in the city 
location, and particularly with city housing developments.
Although published data relating geographical location of cot death victims 
within cities in Scotland is limited (Ameil et al., 1985,
Bartholemew et al., 1987) studies representing the rest of the UK, 
from Cardiff, Sheffield (Emery & Taylor, 1988) and London/Cambridge 
(Golding et al., 1985) have shown increased numbers of cot death 
cases to be in densely populated areas of these cities rather than 
rural areas, however population statistics for the two areas cancelled 
this factor. Studies carried out in the USA (Kelly & Shannon, 1982) 
have looked at geographical location on a much broader perspective.
The monthly distribution of the study cases indicated that a winter 
predominance, December-April, was likely although several discrepancies 
were noted i.e. a larger number of cases occurred in Glasgow in
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September 1987 which coincided with an unusually early start to the 
respiratory epidemic for that year as confirmed by the Virology 
Laboratory reports, RHSC, 1987. Most cot deaths were recorded in 
January and September in the Glasgow area, and December and October 
respectively in the Edinburgh data.
Data collected by the Communicable Diseases Unit, Ruchill Hospital 
for Scotland enabled the respiratory epidemics in the Glasgow and 
Edinburgh areas (Figures 8a, 8b, 11a and 11b) to be monitered resulting 
in the conclusion that the paediatric respiratory epidemics tended to 
increase earlier in the Glasgow area before the main respiratory 
epidemic, a feature not noted in the Edinburgh area during the two 
years of the study (CDS Scotland Weekly Reports, 1987-1988). This 
would coincide with the early increase in September in cot death cases 
brought to the Pathology Department, RHSC, Glasgow.
The low numbers of cot death cases in June was observed in
both Glasgow and Edinburgh The high number of cases detected 
between November and April and low or zero cases presented during 
June-August was a feature of cot death epidemiology noted by Nelson 
and colleagues during a survey carried out in the mid 1970's.
Previous studies carried out in the Pathology Department, RHSC, Glasgow 
have indicated that the number of infants dying of cot death at 9-16 
weeks of age was significantly greater than in the younger or older age 
groups (Patrick et al., 1989). The results obtained in this study from
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both Glasgow and Edinburgh correlated with this finding (Tables 12 and 
16). The mean age of the study group was 18 weeks which was similar to 
results published by Valdes-Dapena (1980) and Kelly & Shannon (1982).
A high proportion of cot death infants in this study had various 
non-specific clinical symptoms in the weeks prior to death (56%)
(Table 14). A small percentage of infants were admitted to hospital 
and these included infants suffering from bronchitis or chest infection. 
The remaining infants had more serious illnesses but were discharged prior 
to death. A proportion of infants had mild respiratory (35%) 
symptoms/infection as documented by the parental interviews. Although 
some of the infants were unwell prior to death their condition did not 
give cause for concern as it was considered natural for an infant to 
to have mild and recurrent respiratory infection at a young age.
There was no correlation between the clinical symptoms and the 
pathologists post mortem report.
Beckwith at the International Symposium, 1970 also noted that 50% of 
cases of cot death had respiratory illness two weeks prior to death.
The non SIDS group used for comparison was hospital-based infants 
preventing meaningful analysis of the data. Similarly the paediatric 
death group in the present study were not analysed with respect to 
illness prior to death as all the infants were hospital based and their 
illnesses thought to be of non infectious origin.
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A relatively small proportion of the total cases were eligible for 
triple vaccine and oral polio vaccine and even smaller number of 
infants had received vaccination. The records of vaccination were 
however limited and most infants who were vaccinated had been several 
weeks prior to death. Further discussion of poliovirus vaccination in 
cot death cases is to be found in Chapter 8.
This particular section of the thesis details the background 
information of the cases studied. The increase in number of cases in 
particular months of the year i.e. winter months and the infection 
prior to death were of interest for the subsequent analysis of the 
micro-organisms detected in the cot death cases and the endogenous 
alpha interferon levels. Further analysis has been left to the 
following chapter.
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CHAPTER 7
RESULTS OF EXPERIMENTAL DATA TO DETERMINE THE PRESENCE OF ENDOGENOUS 
ALPHA INTEREERON IN GOT DEATH CASES
Glasgow Cases
7.1.1 ANALYSIS OF POST MORTEM INTERVAL
The post mortem interval was defined for the purpose of this study 
as the time between death and commencing the autopsy. Before the body 
was opened, body fluid specimens, i.e. NPA, heart blood, CSF, urine, 
were taken by aspiration. In seme cases these specimens were taken 
several hours before the autopsy proper. The post mortem interval for 
the cot death cases is presented in Table 17. The largest number of 
samples were obtained between 25-48 hours.
7.1.2 DETECTION AND ISOLATION OF VIRUS
A total of over 1000 samples, post nasal swab, heart, lung, kidney, 
brain, rectosigmoid loop, mesenteric lymph node, mediastinal lymph 
node, CSF and urine were taken, processed and finally inoculated into 
cell culture tubes with usually 5 tests carried out on each specimen to 
identify the presence of virus. A summary of the positive viral 
results is indicated on Table 18. Positive viral results were obtained 
in sixteen cot death cases (16%). A total of 19 viruses were isolated
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TABLE 17
Post Mortem Interval for Glasgow 
Cot Death Cases
Post mortem 
Interval (hours)
Number of Cases
<24 24
25-48 40
49-72 20
73-96+ 16
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TABLE 18
Positive Virus Results by Isolation for Glasgow Cot Death Cases and 
Paediatric Deaths
Cot Death Cases Paediatric Cases
Number of Cases 100 27
Number of virus positive 16 (16%) 5 (18%)
Number virus isolated/detected 19 0
Number with double infection 3 0
RSV 3 3
Influenza A 1 0
Adenovirus 2 0
Rotavirus 4 1
CMV 1 1
Poliovirus type 1 3 0
Poliovirus type 2 3 0
Poliovirus type 3 1 0
Echovirus type 22 1 0
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from these cases. Double infection was noted in three cases: influenza 
A/rotavirus, adenovirus/rotavirus and adenovirus/poliovirus.
The respiratory viruses isolated/detected included RSV found 
in the exfoliated cells from NPA samples from 3 cases using a direct 
immunofluorescence technique (see section 2.1.5). One case of 
influenza A from an infant 53 weeks of age was similarly detected by a 
monoclonal antibody specific to influenza A incorporated in a direct 
immunofluorescence • technique.
Seven viral antigens: influenza virus types A and B, adenovirus, RSV, 
parainfluenza virus types 1, 2 and 3, were used to screen the 100 NPA 
samples obtained from cot death cases for respiratory infection.
The number of positive samples as indicated above shows that 3% of 
total cases were positive for RSV, and only 1% for influenza virus type A.
Adenovirus was isolated in two cases from the post nasal swab and also 
in the mesenteric lymph node in one case. The adenovirus isolated was 
not typed.
Rotavirus was detected in stool samples obtained from rectosigmoid loop 
in a total of four cases. These positive results were confirmed by 
electron microscopy carried out at Regional Virus Laboratory, Ruchill.
CMV was isolated in one case (1%) from a variety of sites i.e. brain, 
kidney, lung, urine.
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Several poliovirus isolates of types 1 (3 cases), 2 (3 cases) and 3 (1 
case) obtained from the sigmoid loop and nasal swab. In this study, 
polioviruses represent 7/16 (43%) of the total positive virus cases. 
Echovirus type 22 was isolated from the brain, mesenteric lymph node, 
sigmoid loop and kidney in one case.
The paediatric deaths were investigated in a similar manner to that of 
the cot deaths. Positive results were obtained in 5 cases (5/27, 18%), 
RSV was detected in 3 cases from the NPA samples. Two cases had 
detectable levels of antigen to rotavirus in stool samples and in one 
case CMV was isolated in the kidney.
All the paediatric death NPA samples were screened for the presence of 
respiratory virus using a direct immunofluorescent technique 
(section 2.1.5). The three positive cases of RSV were detected by this 
method.
7.1.3 CYTOSPIN PREPARATIONS/IMPRESSION SMEARS
The individual anatomic levels of lung as described in section 2.1.6 
from both cot death cases and paediatric deaths were studied at post 
mortem.
In one cot death case RSV was detected in the lower respiratory tract 
i.e. bronchioles and peripheral lung. Ninety nine cases of cot death 
specimens were negative for RSV as were 15 out of the 27 paediatric
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patients examined using the fluorescence technique for this virus.
/
7.1.4 SEROLOGICAL ANALYSIS
The number of cases tested for an antibody response to a range of viral 
antigens: CMV, HSV, VZV, influenza A, adenovirus, mycoplasma pneumonia, 
mumps, measles, was limited by the quantity of serum available. Sixty 
three cot death cases were tested by the complement fixation test and 
yielded no significant titres on 62 cases i.e. titres of <16 were noted 
to all viruses analysed. From the case in which CMV infection was 
proven by viral isolation, a titre of 512 was recorded.
Indirect immunofluorescence tests to a range of viral antigens; HSV,
VZV, RSV, CMV, mumps, measles were used to detect and quantify levels 
of specific IgM titres in a total of 65 cot death cases, however no 
significant IgM titres were detected in these cases.
The paediatric deaths (25 cases) were also tested by complement 
fixation test and indirect immunofluorescence. . *' v "-.
The presence of IgM was not detected in serum samples.
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7.1 .5 BACTERIOLOGICAL EXAMINATION OF POST MORTEM MATERIAL
Routine bacteriology was carried out on the cot death samples.
From the 100 cot death samples, microorganisms were recovered by 
culture from either lung fluid, heart blood, CSF or tissue samples in 
56 infants. No evidence of growth was noted on the remaining 44 cases 
in the study after 7 days incubation.
The organisms recovered included 23 cases of coagulase negative 
Staphylococcus (42%). Nineteen of these bacteria were cultured from 
the heart blood, 2 from lung fluid, 1 in CSF and 1 in a brain sample. 
Haemophilus influenzae was isolated in 4 cases, 3 in lung fluid and 1 
from a CSF sample. Streptococcus pneumoniae was recovered from the 
lung fluid and heart blood from five cot death cases. Three cases of a 
group B Streptococcus were cultured fran the lung fluid specimens.
The cot death cases with evidence of bacterial culture and pathological 
reports to support minor abnormalities in histological sections were 
categorised by the pathologists into grouping 3BB i.e. where the 
findings were not thought to be sufficient to cause the death.
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Edinburgh Cases
7.1.6 ANALYSIS OF POST MORTEM INTERVAL
The post mortem interval calculated for fluid specimens obtained from 
Edinburgh cases of cot deaths is represented in Table 19. Forty four 
cases out of the total 98 cases (44%) of samples were collected between 
25-48 hours, as previously observed in the Glasgow data.
7.1.7 DETECTION AND ISOLATION OF VIRUS
The body fluids and tissue specimen collected as detailed in section 
2.1.2. were analysed for the presence of virus at the Regional Virus 
Laboratory, City Hospital, Edinburgh.
The positive viral results are presented in Table 20. A total of 39 
viruses were isolated from 33 positive viral cases (38%) from the 87 
cot death cases studied. Six cases presented with double infection: 
Rhinovirus/Echovirus type 22, CMV/Polio 2, Rhinovirus/Coxsackie A, 
Echovirus type 22/RSV, CMV/Polio 2 and Polio type 1/Polio type 3.
Respiratory viruses detected from the specimens collected included, 6 
cases of RSV isolated from the tracheal ring, NPA and nasal/throat 
swab. Adenovirus was noted in 4 cases: 2 isolated from one site only
i.e. the ileal loop and bronchial swab? and in two other cases from a. 
variety of sites,.
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TABLE 19
Post Mortem Interval for Eflinburgh 
Cot Death Cases
Post mortem 
Interval (hours)
Number of Cases
<24 20
25-48 44
49-72 20
73-96+ 13
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TABLE 20
Positive Virus Isolation Results for Cot Death Cases, 
Edinburgh
Cot Death Cases
Number of Cases 87
Number of Virus Positive Cases 33 (38%)
Number of viruses isolated 39
Number with double infection 6
RSV 6
Adenovirus 4
Parainfluenza type 3 2
Ehinovirus 4
Rotavirus 1
cm 3
Poliovirus type 1 4
Poliovirus type 2 4
Poliovirus type 3 2
Coxsackie A* 1
Coxsackie B* 1
Echo Virus type 11 3
Echo Virus type 22 4
* = type unknown
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, Parainfluenza type 3 was detected in the bronchial swabs fran two 
cot death cases. Rhinovirus was isolated from the upper respiratory 
tract, nasal swab and tracheal ring in 4 cases. Rotavirus was detected 
in the ileal loop in only one case.
In three cot death cases CMV was isolated frcm kidney specimens t.
The Coxsackie virus types A and B represented one case each. These 
viruses were isolated/detected in ileal loop and bronchial swab.
Echovirus typed as 11 and 22 were also noted in 3 cases and 4 cases, 
respectively and were isolated from the tracheal ring sample, ileal 
loop and faeces. The poliovirus type 1 (4 cases), type 2 (4 cases) 
and type 3 (2 cases) represented 9 cases fran the total 33 cot death 
cases(27%) with positive virus isolation.
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ANALYSIS OF INTERFERON- oi LEVELS IN GLASGOW AND EDINBURGH GOT 
DEATH CASES AND PAEDIATRIC DEATHS
The measurement of IFN- o< levels in body fluids, serum, CSF, NPA was 
carried out using "Sucrosep IFN- oC 11 IRMA as in section 2.1.8. Levels 
of IFN- o( detected in the cot death specimens collected from Glasgow 
and Edinburgh are plotted in figures 12 and 13. A group of 
paediatric deaths were analysed in parallel with the cot death cases 
and the IFN- ct levels in fluid samples are shown in figure 14.
7.2.1 INTERFERON- LEVELS IN NASOPHARYNGEAL ASPIRATE (NPA)
Nasopharyngeal aspirate samples diluted 1:10 in VTM were collected fran 
97 cot death cases fran Glasgow, 90 cases of cot death from the 
Edinburgh area and a group of 22 paediatric deaths and investigated 
for the presence of IFN- o( . The number of cot death cases and 
paediatric cases in the individual IFN- o< ranges 0 - 1  IU/ml, 1 . 1 - 1 0  
IU/ml, 10.1 - 100 IU/ml and >100 IU/ml were analysed (Table 21). The 
highest number of Glasgow cases (37%) were noted in the 10.1 - 100 IU/ml 
IFN- oC range, however, the 0 - 1  IU/ml and 1.1 - 10 IU/ml IFN- o( were 
shown to have 34% and 27% of cases, respectively. The number of cases 
in each IFN- c< range were similar.
The Edinburgh cot death samples of NPA in each IFN- range, 35% in 
0 - 1 IU/ml and 31% in 1.1 - 10 IU/ml and 10.1 - 100 IU/ml ranges,
showed a similar pattern of case distribution in IFN- oC levels as
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TABLE 21
Range of IFN- cX Level Present in NPA in Glasgow 
and Edinburgh Got Death Cases and Paediatric Deaths
CASES
IFN-o'
IU/ml
Glasgow
(%)
Edinburgh
(%)
Paediatric
(%)
0 - 1 33/97 (34) 32/90 (35) 6/62 (28)
1.1 - 10 26/97 (27) 28/90 (31) 12/21 (57)
10.1 - 100 36/97 (37) 28/90 (31) 3/21 (14)
> 100 1/97 ( 1) 2/90 ( 2) 0/21 ( 0)
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noted for the Glasgow cases.
Analysis of the total cot death group (186 cases) indicated that 64 
cases (34%) had IFN- oC values >10 IU/ml and hence these samples would 
be positive for IFN- c( by any assay system.
Paediatric deaths were evaluated over the IFN- Grange 0 - 1 2  IU/ml.
The number of cases detected in 1.1 - 10 IU/ml range were 12/21 (57%), 
however only 3 cases (14%) of cases had levels of IFN-o(>10 IU/ml.
Using the previously derived minimum detection limits (see section 
3.1.3) , the number of NPA samples with IFN- o( values ^ 2 IU/ml 
in the Glasgow cot death cases was 59 (60%) and in cases collected from 
Edinburgh, 51 (53%), see Table 22. The paediatric death data was 
analysed similarly and indicated that 14 (63%) of NPA samples showed 
the presence of IFN- oC above 2 IU/ml. The mean values of IFN-c(in 
NPA y/2 IU/ml were 20.56 IU/ml for Glasgow cot death cases, 20.5 IU/ml 
for Edinburgh cot death cases and 7.6 IU/ml for paediatric cases and 
these results highlight the IFN- o( range data shown in Table 23.
Statistical analysis was carried out using the Mann-Whitney U-test. No 
statistical significance (P>0.05) was observed between the values of 
IFN- oi detected in the NPA from cot death specimens and paediatric 
deaths.
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TABLE 22
Analysis of IFN- oC Levels in Nasopharyngeal Aspirate in 
Glasgow and Edinburgh Cot Death Cases and Paediatric Deaths
NUMBER NUMBER
OF CASES OF CASES MEAN VALUE P
CASES STUDIED >2 IU/ml (%)' of IFN- OC VALUE
1 1, 3
GLASGOW
COT DEATHS 97 59 (60) 20.56
>0.05
EDINBURGH 2 - >0.05
COT DEATHS 90 51 (53) 20.5
PAEDIATRIC3
>0.05
V  ? DEATHS 22 14 (63) 7.6
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TABLE 23
Comparison of NPA IFN- o( Levels in Cot Death Cases and 
Paediatric Patients Presenting with Acute Respiratory 
Infection
Glasgow 1985-86(Salas, 1988)
IFN-C*
IU/ml
Glasgow/Edinburgh 
Cot Death 
(1987-89) (%)
Pneumonia
(%)
Chronic Lung 
Disease
(%)
0 - 1 65/187 (35) 15/51 (29) 8/15 (53)
1.1 - 10 54/187 (29) 13/51 (26) 2/15 (13)
10.1 - 100 64/187 (34) 15/51 (29) 4/15 (27)
> 100 3/187 ( 2) 7/51 (14) 1/15 ( 6)
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Comparisons of the IFN- oC levels in NPA samples obtained from 
paediatric patients during a repiratory virus epidemic (Salas, 1988) 
and the current NPA IFN- oC data collected from the combined Glasgow 
and Edinburgh cot death group are documented in Tables 23 and 24 .
The IFN- ot values were obtained using identical laboratory techniques 
and under the same conditions at the Virus Laboratory, RHSC, Glasgow.
The data revealed a striking similarity of IFN- levels in the cot 
death cases and the paediatric patient presenting with pneumonia and 
chronic lung disease (Table 23) compared to the bronchiolitis/URTI 
group (Table 24). Both the study group and the pneumonic cases had IFN- oC 
levels 10.1 - 100 IU/ml in the order of 30% suggesting significant 
virus associated lower respiratory tract infection in both groups.
This result is surprising in view of the lack of significant clinical 
disease or pathology in the cot death cases.
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TEBDE 24
Cbtgarisan. c f N2&. IBN-oC levels in Cbfc Death (hses and E&adiatric E&fcieribs 
Enesentdng with Rs^aiatrny Illness
Glasgow 1985-86(sal*s, 1988)
IEN-oC
U M
Glasgaw/ffliifaagh
CbtDsath
(1987-89)
(%)
BccniiiriLitis
(%)
UREC
(%)
Others
(%)
0-1 65/187 (35) 39/95 (41) 20/29 (69) 12/18 (67)
1.1 -10 54/187 (29) 28/95 (29) 4/29 (13) 4/18 (22)
10.1 - 100 64/187 (34) 18/95 (19) 2/29 ( 7) 1/18 ( 5)
>100 3/87 (2 ) 7/95 ( 7) 4/29 (13) 1/18 ( 5)
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7.2.2 INTERFERON- oC LEVELS IN SERUM
A total of 99 Glasgow cot death cases, 92 Edinburgh cot death cases and 
26 paediatric deaths were tested for the presence of IFN- oC in serum 
samples.
The IFN- o( data was analysed with respect to the number of cases 
categorised into several IFN- oC ranges of the cot death cases and 
paediatric deaths as indicated in Table 25. Similar trends in the 
number of cases of Glasgow, Edinburgh cot death and paediatric deaths 
were noted in the IFN- c< ranges 0 - 1  IU/ml and 1.1 - 10 IU/ml. The 
highest proportion of cases 54% for the combined levels of IFN- oC 
in the cot death group and 62% for the paediatric deaths was noted in
the IFN- oi range 12.1 - 100 IU/ml. Only the cot death cases had
levels >10 IU/ml in serum samples (5%).
Further analysis of serum IFN- lvalues (Table 26) indicated that 58
specimens (58%) of Glasgow cot death cases had IFN- oC levels >1.5
IU/ml. Similarly, 31 (34%) of serum samples from Edinburgh cot death 
cases were >1.5 IU/ml IFN- oC. In the paediatric deaths group 
12 (46%) samples had IFN- oC levels >1.5 IU/ml. The mean levels of 
specimens >1.5 IU/ml was 8.06 IU/ml for Glasgow cases, 5.9 IU/ml for 
cases of cot death from Edinburgh and 2.96 IU/ml for paediatric deaths. 
Statistical analysis was carried out on the total IFN- o( levels in 
serum samples in the three study groups and found not to be significant 
by Mann Whitney U-test (P>0.05).
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TABLE 25
Range of Interferon d  Levels in Serum in 
Glasgow and Edinburgh Cot Deaths and 
Paediatric Deaths
CASES
Range of 
IFN- oC 
IU/ml
Glasgow
(%)
Edinburgh
(%)
Paediatric
(%)
0 - 1 29/99 (29) 37/92 (40) 10/26 (38)
1.1 - 10 61/99 (62) 52/92 (56) 16/26 (62)
10.1 - 100 9/99 ( 9) 2/92 ( 2) 0/26 ( 0)
>100 0/99 ( 0) 0/92 ( 0) 0/26 ( 0)
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TABLE 26
Analysis of IFN- o( Levels in Serum Samples in 
Glasgow and Edinburgh Cot Death Cases and 
Paediatric Deaths
Number Number Mean Value
of Cases of Cases of IFN -oC P
Cases Studied >1.5 IU/ml (%) >1.5 IU.ml Value
Glasgow 1 r- _1, 3
Cot Deaths 99 58 (58) 8.06
>0.05
Edinburgh 2 - >0.05
Cot Deaths 92 31 (34) 5.9
>0.05
Paediatric?
Deaths 26 12 (46) 2.96
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7.2.3 INTERFERON- oL LEVELS IN CSF
Samples of CSF frcm 99 cases of Glasgow cot deaths, 96 Edinburgh 
cot death cases and a group of 26 paediatric deaths were examined for 
the presence of IFN- . The number of cases analysed in each 
individual IFN- oi range is indicated in Table 27 and 28.
The combined analysis of the Glasgow and Edinburgh cot death groups 
indicated that the number of cases with IFN- o( levels between
1.1 - 10 IU/ml in CSF was double (66%) the number of cases observed in 
the 0 - 1  IU/ml range (32%). The paediatric death data concurs with the 
results of the cot death cases. One level of IFN- c/ was detected in the
10.1 - 100 IU/ml range for a CSF sample from a cot death. IFN- o< levels 
were not detected in the paediatric death group at levels >10 IU/ml.
The minimum detection limit of >1.5 IU/ml was used in the study for 
IFN- oC in CSF samples (see section 3.1.3). Sixty (61%) of the Glasgow 
samples had levels of >1.5 IU/ml IFN- o( and 41 (34%) of CSF specimens 
from Edinburgh cot deaths had similar raised levels. Paediatric deaths 
were also analysed and showed 12 (46%) cases had IFN- o( levels >1.5 
IU/ml.
The mean levels evaluated for the CSF samples >1.5 IU/ml IFN- oC were 
3.08 IU/ml in Glasgow cot death cases, 2.0 IU/ml in Edinburgh cot death 
cases and 3 IU/ml in paediatric cases. The Mann Whitney U- test was 
used to statistically analyse the CSF IFN- oC data.
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TABLE 27
Range of Interferon o( Present in 
CSF Samples from Glasgow and Edinburgh 
Cot Deaths and Paediatric Deaths
CASES
IFN- oi Glasgow Edinburgh Paediatrics
IU/ml (%) (%) (%)
0 - 1 26/99 (26) 36/93 (39) 11/26 (42)
1.1 - 10 72/99 (73) 56/93 (60) 15/26 (58)
10.1 - 100 0/99 ( 0) 1/93 ( 1) 0/26 ( 0)
> 100 0/99 ( 0) 0/93 ( 0) 0/26 ( 0)
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TEELE 28
Analysis cf UN- levels in  CSF Sfenples in  Glasgow and 
Bdjjrhurgh Obt Death Cases and l&ediatrie Deaths
Chses
NLnber 
c f Chsas 
Studied
R nte: 
of Chses 
>1.5 ID/ml (%)
Mean Value P 
c f IEN-<* V&boe
Glasgow 1 - r1,3
Cbt Deaths 99 60 (61) 3.08
p >0.05
EiLrtagh — >0.05
Cbt Deaths 93 41 (34) 2.8
•3 >0.05
Ibediatrijc Deaths 26 12 (46) 3.0 -
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No difference in overall IFN- ot values was noted between the two cot 
death groups or on comparison with the paediatric death group (P >0.05).
7.2.4 INTERFERON- cL RESULTS FOR VIRUS POSITIVE GOT DEATH CASES;
GLASGOW AND EDINBURGH AND PAEDIATRIC DEATHS
A range of viruses were detected/isolated in both cot death cases frcm 
the Glasgow and Edinburgh cases as well as paediatric deaths as 
documented in section 7.1.2 and the IFN- ^ levels are documented in 
Tables 29, 30 and 31.
Samples of NPA, serum and CSF from the 16 (16%) virus positive cases of 
Glasgow cot deaths and 30 (34%) of the 33 cases of cot death from 
Edinburgh had sufficient specimen for IFN- obtesting. Five (18%) of the 
27 paediatric deaths were found to be positive for virus. Paediatric 
deaths were investigated for IFN- oi in parallel with the cot death cases.
Hie range of IFN- (A levels observed in virus positive cases of Glasgow 
cot death cases are illustrated in figure 15. A similar figure was 
collated for the Edinburgh cot death data, see figure 16. The number 
of cases in each IFN- oC range for cot deaths and paediatric deaths are 
shown in Tables 32 and 33.
The range of IFN- (/values for NPA samples from Glasgow and Edinburgh 
cot deaths was between 0 - >100 IU/ml, with 2 cases >100 IU/ml. The
ALPHA INTERFERON LEVELS IN NPA, SERUM, CSF IN 
VIRUS POSITIVE COT DEATH CASES,
ROYAL HOSPITAL FOR SICK CHILDREN, GLASGOW
cpm
1000n
100-
E
3 
^ 10-
i
zu_
NPA SERUM CSF
BODY FLUIDS
Figure 15
ALPHA-INTERFERON LEVELS IN NPA, SERUM, CSF I 
VIRUS POSITIVE COT DEATH CASES 
ROYAL HOSPITAL FOR SICK CHILDREN, EDINBURGH
cpm
10001
100-1
V  ‘.10
i
z:
U-
1-
NPA
 - mean
SERUM 
BODY FLUIDS
CSF
Figure 16
135
TABLE 29
Alpha Interferon Levels from Virus Positive Glasgow Cot Death Cases
Number of Case Virus Detected
IFN-
NPA
<£ (IU/ml) 
SERUM CSF
1 RSV 0 8.4 3.6
2 RSV 0 5.6 0
3 RSV 16 21 3.4
4 Rotavirus 1 4.6 2.3
5 Rotavirus 0 38 1.5
6 Echo type 22 0 2 1
7 CMV 17 0.4 2.5
8 Polio type 1 15 0.1 0.7
9 Polio type 1 20 0.7 1.4
10 Polio type 2 1 12 3.4
11 Polio type 2 0 0.7 4.2
12 Polio type 3 3 1.1 2.5
13 Influenza A/Rotavirus 240 55 4
14 Adeno/Rotavirus 0 3.8 2.1
15 Adeno/Polio 15 4 1.7
16 Polio types 1 and 2 10 4 1.1
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TABLE 30
Alpha Interferon Levels from Virus Positive Edinburgh Cot Death Cases
Number of Case Virus Detected/Isolated
IFN-
NPA
(U/ml) 
SERUM CSF
1 RSV 17 1.2 2.2
2 RSV 0 0.2 0.2
3 RSV 3.6 0.4 1.8
4 RSV 4 0 1.05
5 RSV 0 0 3.1
6 Adenovirus 20 6.5 2.8
7 Adenovirus 11 1.3 1.7
8 Adenovirus 6 2.2 1.1
9 Adenovirus 6 3.2 0.2
10 Parainfluenzae 3 0 6 3
11 Rhinovirus 3 7 1.4 1.6
12 Rhino 0 2.1 0.4
13 Rotavirus 1.0 1.1 1.0
14 CMV 42 0.6 1.6
15 Polio type 1 0 0 0.5
16 Polio type 1 28 0.5 0.5
17 Polio type 1 28 2.8 1.3
18 Polio type 2 11 0.6 2.2
19 Polio type 2 3.2 6.1 2.2
20 Polio type 3 0 1.1 1.3
21 Coxsackie B 240 1.2 17
22 Echo type 11 1.1 2.2 0.7
23 Echo type 11 21 3 0.1
24 Echo type 22 0.1 0 0
25 Echo type 22 14 7.5 1.4
26 Polio type 1/3 26 64 0.3
27 CMV/Polio 2 0 1.4 1.8
28 Rhino/Coxsackie A 8 1.6 2
29 RSV/Echo type 11 3 5.5 4
30 CMV/Polio 2 1.5 1.2 2
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TABLE 31
Alpha Interferon Levels from Virus Positive Paediatric Deaths
Number of Case Virus Detected/Isolated
IFN-
NPA
oi (U/ml) 
SERUM CSF
1 RSV 1.2 0.7 1.7
2 RSV 20 5.4 0.12
3 RSV 0 6 1.2
4 CMV 0 2.3 1.5
5 Rotavirus 1.2 NT 1.8
NT = not tested
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TEHE32
Analysis c£ I&nge cf IEN-^Results for Virus Rasitfe Glasgow ard BUrfauc^ i Gbt Deaths
r o M G
N a
(%) E (%) G
SEHM 
(%) E (%) G
CSF
(%) E (%)
0-1 8/16 (50) 10/30 (32) 4/16 (25) 10/30 (32) 3/16 (19) 11/30 (35)
1.1 -10 2/16 (12) 11/30 (35) 8/16 (50) 20/30 (65) 13/16 (81) 19/30 (61)
10.1 - 100 5/16 (31) 9/30 (29) 4/16 (25) 1/30 ( 3) 0/16 ( 0) 1/30 ( 3)
>100 1/16 ( 6) 1/30 ( 3) 0/16 ( 0) 0/30 ( 0) 0/16 ( 0) 0/30 ( 0)
G = Glasgow 
E = Bairbucgh
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TABLE 33
Range of Interferon oC Levels for 
Virus Positive Paediatric Deaths
IFN-
(IU/ml) NPA (%) SERUM (%) CSF (%)
0 - 1 2/5 (40) 1/4 (25) 1/5 (20)
1.1 - 10 2/5 (40) 3/4 (75) 4/5 (80)
10.1 - 100 1/5 (20) 0/4 ( 0) 0/5 ( 0)
>100 0/5 ( 0) 0/4 ( 0) 0/5) ( 0)
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largest number of cases was found between 0 - 1 0  IU/ml i.e. 62% and 
67% respectively. In 46 cot death cases from Glasgow and Edinburgh 30% 
of NPA samples had IFN- levels ) 10 IU/ml. Serum levels of IFN- ^  
were also noted between 0 - 1 0 0  IU/ml with the largest number of cases 
(57%) observed in the 1.1 - 10 IU/ml range. Fourteen per cent of the 
total cot death group had IFN- oCvalues in the range 10.1 - 100 IU/ml. 
CSF levels of IFN- for the cot death cases were noted between 
0 - 1 0  IU/ml with the largest number of cases in the IFN- ot range
1.1 - 10 IU/ml i.e. 32/46 (71%) of total cot death cases and only 1 case 
(3%) had IFN- c* >10 IU/ml.
The serum and CSF samples in virus positive paediatric deaths were 
similarly noted as in the cot death cases to be between 0 and 10 IU/ml, 
with increased numbers of 75% and 80% in cases in the 1.1 - 10 IU/ml 
IFN- o( range. The NPA samples showed IFN- U  levels between
0 - 1 0 0  IU/ml with 20% of cases with IFN- c£ levels of 10.1 - 100 IU/ml.
Analysis of the IFN- oC data for virus positive cot deaths and 
paediatric deaths is presented in Table 34. Levels greater than the 
minimum detection limit for IFN- c* IU/ml in the NPA were detected in 
8 (50%) cot death cases from Glasgow. Twenty Edinburgh cot death cases 
(67%) were above the cut level of 2 IU/ml and only one case in the 
paediatric death group was noted. The mean levels of IFN- oC detected 
above 2 IU/ml in the NPA were 42, 23.6 and 20 IU/ml for Glasgow, 
Edinburgh cot death cases and paediatric deaths. The number of virus
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TABLE 34
Analysis of Alpha Interferon Results for Virus Positive Glasgow and Edinburgh 
Got Death Cases and Paediatric Deaths
Cases
Samples
Studied
Number 
of Cases
Number 
of Cases 
IFN-oC Positive (%)
Mean
Value (U/ml)
NPA 16 8 (50) 42
Glasgow Serum 16 11 (68) 14.4
Cot Death CSF 16 11 (68) 2.8
NPA 30 20 (67) 23.6
Edinburgh Serum 30 13 (43) 8.6
Cot Deaths CSF 30 16 (53) 3.2
NPA 5 1 (20) 20
Paediatric Serum 4 3 (75) 4.5
Deaths CSF 5 3 (60) 1.6
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positive paediatric deaths is too small for meaningful analysis.
Evaluation of the levels of IFN- ^present in serum, >1.5 IU/ml were 
carried out on 11 (68%), 13 (43%) and 3 (75%) of virus positive 
Glasgow, Edinburgh cot deaths and paediatric deaths. The mean levels 
were calculated as 14.4, 8.6 and 4.5 IU/ml IFN- oC for the cot death 
groups and paediatric group.
Similarly CSF samples >1.5 IU/ml IFN- o( were analysed. The number of 
cases above the minimum detection limit were shown to be 11 (68%),
16 (53%) and 3 (60%) for Glasgow, Edinburgh cot death and paediatric cases.
7.2.5 INTERFERON- (A RESULTS FOR VIRUS NEGATIVE GOT DEATH CASES,
GLASGOW AND EDINBURGH AND PAEDIATRIC DEATHS
Specimens: NPA, serum and CSF were tested for the presence of IFN- ot
from the cot death cases and paediatric cases in which no viral isolate 
was obtained. The range of IFN- o( values obtained from Glasgow and
Edinburgh virus negative cot death cases are shown in figures 17 and 18.
The number of cases were analysed in each IFN- o( range for cot deaths 
and paediatric deaths 0 - 1  IU/ml, 1.1 - 10 IU/ml, 10.1 — 100 IU/ml and
>100 IU/ml are illustrated in Tables 35 and 36 .
The NPA samples from 81 Glasgow cot death cases and 62 cases of cot 
death collected from Edinburgh indicated a range of IFN- o( levels 
between 0 - 1 0 0  IU/ml. The number of cases in the individual ranges
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TABCE 35
I&nge cf IEN- eCRsaiLts fear Virus Ifegafcive Glasgow and Eaiiixcgh Gbt Deaths
IEN- oC 
i u M G
NPA
(%) E (%) G
SEKM 
(%) E (%) G
CSF
(%) E (%)
0-1 25/81 (31) 22/59 (37) 25/83 (30) 27/60 (44) 23/82 (25) 25/62 (40)
1.1 -10 24/81 (30) 17/59 (29) 53/83 (64) 32/60 (52) 59/82 (71) 37/62 (60)
10.1-100 31/81 (39) 19/59 (32) 5/83 ( 6) 1/16 (2) 0/82 ( 0) 0/62 ( 0)
>100 0/81 ( 0) 1/59 ( 2) 0/83 ( 0) 0/60 ( 0) 0/82 (0) 0/62 ( 0)
G = Glasgow 
E = Efiirburgh
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TABLE 36
Range of Alpha Interferon Results for 
Virus Negative Paediatric Deaths
IFN-
IU/ml NPA (%) SERUM (%) CSF (%)
0 - 1 4/16 (25) 9/12 (41) 10/21 (48)
1.1 - 10 10.16 (62) 13/22 (59) 11/21 (52)
10.1 - 100 2/16 (12) 0/22 ( 0) 0/21 ( 0)
>100 0/16 ( 0) 0/22 ( 0) 0/21 ( 0)
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for both cot death groups showed a constant pattern of between 30 - 40%.
The IFN- oC level in serum was tested in 83 Glasgow cot death cases and 
55 Edinburgh cot death cases. The range of IFN- oC values in virus 
negative cot death cases was between 0 - 1 0 0  IU/ml, with peak numbers 
of cases noted in the 1.1 - 10 IU/ml grouping, 58% of total cot death 
cases.
The CSF samples from virus negative cot death cases from Glasgow (83 
cases) and Edinburgh (59 cases) had IFN- oC levels of 1.1 - 10 IU/ml in 
71 and 60% of cases, respectively. No IFN- oC levels were detected in 
the CSF specimens above 10 IU/ml.
The cot deaths showed IFN- oC values between 0 - 100 IU/ml in NPA
specimens ( 16 cases) from virus negative cases, 12% of cases 
in the range 10 - 100 IU/ml. The serum and CSF samples ( 21 cases each) 
had levels of IFN- o( in the range 0 - 1 0  IU/ml. The largest proportion of 
cases with IFN- oC found in the all three samples was detected between
1.1 - 10 IU/ml i.e. 62%, 59% and 52% in NPA, serum and CSF.
An indication of the number of Glasgow and Edinburgh cot death cases 
with IFN- ot levels above the minimum detection limits previously set 
for NPA, serum and CSF samples are shown in Table 37. The mean values 
of IFN- o( were obtained on a smaller number of cases therefore 
increasing the IFN- detected in NPA i.e. 17.8 IU/ml and 18.5 IU/ml,
serum 6.36 IU/ml and 3.64 IU/ml and CSF 2.9 IU/ml and 2.3 IU/ml. The
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TABLE 37
Analysis of IEN- Results for Virus Negative Glasgow and 
Edinburgh Cot Death Cases and Paediatric Deaths
Cases
Samples
Studied
Number 
of Cases > 2 IU/ml
Number 
of Cases 
>1.5 IU/ml (%)
Mean
Value
U/ml
NPA 81 51 (63) 17.8
Glasgow Serum 83 45 (54) 6.36
Cot Deaths CSF 83 50 (60) 2.9
NPA 62 32 (52) 18.5
Edinburgh Serum 55 20 (36) 3.64
Cot Deaths CSF 59 29 (49) 2.3
NPA 16 12 (75) 6.6
Paediatric Serum 21 10 (48) 2.49
Deaths CSF 21 9 (43) 3.4
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IFN- ^values from samples obtained from negative cot death cases in
the study showed similar ranges of level of IFN- present. The
IFN- oi levels in NPA samples from paediatric deaths were lower 
than the cot death cases. The mean IFN- oC level was 6.6 IU/ml. The 
serum and CSF IFN- oC levels in paediatric deaths were similar to those 
detected in cot death samples.
Analysis of the virus positive and virus negative cases of cot death
using the Wilcoxon Rank Sum test indicated that there was no significant 
difference between the levels of IFN- o( in NPA obtained in viral 
positive and viral negative cases, although the total mean IFN- oC 
values appear to be higher in viral positive cases i.e. 21.11 and
11.3 IU/ml. The high mean IFN- oi values in NPA were due to the 
several values > 200 IU/ml which increased the range of detectable 
levels. No significant difference was noted in the serum and CSF 
levels of IFN- o< of the virus positive and negative case of Glasgow and 
Edinburgh cot death cases.
The mean IFN- values of samples from the paediatric deaths were lower 
than those noted for cot death cases, but again no statistical 
difference was noted between the IFN- (X levels in NPA, serum and CSF in 
paediatric viral positive or negative cases and the viral positive and 
negative cases of cot death.
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7.3.1 INTERFERCB- LEVELS AND AGE DISTRIBUTION IN GLASGOW GOT DEATH 
CASES
The Glasgow cot death cases were investigated for positive IFN- 
levels in the fluid samples; NPA, serum and CSF and the age 
distribution of the infants as shown in Table 38. The number of 
cases with raised IFN- ot values in the NPA and CSF were similar over 
the age ranges 1 - 8  weeks to 27 - 52 weeks, i.e. Fifty per cent of 
cases. The serum samples with detectable levels of IFN- had 
increased numbers of cases presented in the 9 - 1 6  week age group.
Despite the above trends, on statistical evaluation using Wilcoxon Rank 
test, no evidence was found to suggest that the age of the cot death 
victims was a factor in the increase of IFN- oC levels detected in the 
fluid samples obtained from the body.
Edinburgh Cot Death Cases
The detection of IFN- oC levels in the body fluids in Edinburgh cot 
death cases was analysed with respect to the age of the infant at the 
time of sampling. The data collected for numbers of cot death cases in 
the age ranges 1 - 8 ,  9 - 1 6 ,  1 7 - 2 6  and 27- 52 weeks and increased 
values of IFN- are detailed in Table 39. It was noted that the 
number of infants with increased IFN- o< levels in the NPA occurred 
between 9 - 1 6  weeks and 1 7 - 2 6  weeks although no increase in IFN- oC 
values was noted for CSF over the age ranges. There was an increase in
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TABLE 38
Interferon oi Levels and Age Distribution of Glasgow Cot Death Cases
Body Fluids
Age
(weeks)
NPA 
>2 IU/ml (%)
SERUM 
>1.5 IU/ml (%)
CSF 
>1.5 IU/ml (%)
1-8 15/23 (65) 11/23 (48) 12/23 (52)
9-16 21 /39 (54) 27/39 (69) 22/39 (56)
17-26 13/22 (59) 7/22 (32) 10/22 (45)
27-52 9/16 (56) 9/16 (56) 11/16 (69)
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TABLE 39
Interferon Levels and Age Distribution of Edinburgh Cot Death Cases
Body Fluids
Age (weeks)
NPA 
>2 IU/ml (%)
SERUM 
>1.5 IU/ml (%)
CSF 
>1.5 IU/ml (%)
1-8 5/18 (28) 5/18 (28) 8/18 (44)
9-16 25/34 (73) 20/34 (29) 15/34 (44)
17-26 14/21 (66) 9/21 (43) 10/21 (47)
27-52 8/16 (50) 7/16 (44) 8/16 (50)
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the number of cases with raised IFN- qC in the 1 7 - 2 6  week age group.
7.3.2 INTERFERON- cL RESULTS AND POST MORTEM INTERVAL FOR GLASGOW 
COT DEATH CASES
Analysis of the post mortem interval and the number of cot death cases 
with IFN- o( above the minimum detection limits in the body fluid 
specimens are shown in Table 40.
Similar number of cases were observed in the 24 hours and 25 - 48 hour 
intervals for NPA, serum and CSF sampling. The cases with raised 
serum IFN- oL levels in 49 - 72 hours interval were higher in number 
than in NPA or CSF. This trend was also noted in the CSF IFN- oC values 
in the 73 - 96+ hour post mortem interval.
Statistical analysis using the Wilcoxon Rank test indicated that there 
was no significant differences in the IFN- oC levels observed in any of 
the specimens compared with the time interval at which the samples were 
taken. This result was despite apparent increases in the number of 
specimens with raised IFN- cL in CSF and serum and 49 - 72 hours and 
73 - 96+ sampling after death of the cot death victim.
Edinburgh Cot Death Cases
The number of cases of Edinburgh cot death specimens with IFN- oC 
detected ^2 IU/ml for NPA and .5 IU/ml in serum and CSF
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TABLE 40
Positive Levels of IFN o( and Post Morten Interval for Glasgow Cot Death Cases
PM
Interval
(Hrs)
NPA 
>/2 IU/ml
Body Fluids IFN- 
SERUM 
(%) £1.5 IU/ml
o<
(%)
CSF 
£1.5 IU/ml (%)
24 6/12 (50) 6/12 (50) 6/12 (50)
25-48 15/29 (52) 14/29 (48) 16/29 (55)
49-72 5/9 (55) 7/9 (77) 6/9 (66)
73-96 4/7 (57) 4/7 (57) 6/7 (85)
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samples are presented in Table 41.
No real difference was noted in the number of cases with raised IFN- oC 
in each post mortem range in the samples tested. A larger proportion 
of cases tested for IFN- in NPA specimens were detected in the 
49 - 72 hour post mortem interval (50%) compared to the serum and CSF 
samples at the same time interval. A similar trend was noted for 
IFN- levels in NPA samples in the 25 - 48 hour post mortem interval.
7.4.1 analysis o f ifn-^( in l u n g sections
From the Glasgow cot death cases and paediatric deaths serial sections 
of lung specimens - pharynx, larynx, trachea, bronchus, bronchioles and 
peripheral lung see section 2.1.6 were cut into 4 pm sections and 
placed on coated slides. The positive cells in the sections were 
observed by microscopic examination and scored on a system based on 
visual analysis.
The scoring system ranged from 0 to >16 positive cells per high power 
field (x40, 1400 square microns) as a mean value over a series of 5 
microscope fields. The number of positive cells observed were 
categorised into 0, 1 -5, 6 - 1 0 ,  11 -15, >16 cells and given the 
graded values 0 to 4 for each grouping of positivity, see Table 43.
From a total of 100 Glasgow cot death cases, 94 cases were processed 
using the 'in situ1 technique. Five paediatric deaths were evaluated
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rm K E  41
Eteitive levels c£ UN- oC and Itet Mxten Interval fa: Eairixnxfr Gbt Eteath Cases
EM Interval 
(ftcs)
NPA
>2 IU/ml (%)
Body Fluids UN- o( 
SEKM
>1.5 lU/ml (%)
CSF
>1.5 IU/ml (%)
<24 9/20 (45) 6/20 (30) 8/20 (40)
25-48 26/44 (59) 14/44 (32) 22/44 (50)
49-72 10/20 (50) 6/20 (30) 7/20 (35)
73 - 96+ 6/13 (46) 5/13 (38) 4/13 (31)
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similarly to the cot death cases.
The lung sections: pharynx, larynx, trachea, bronchus and bronchioles
were tested and the results of the positivity specific to IFN- oC in the 
cells is detailed in Table 42.
No IFN- (£. positive cells were noted in the pharynx, larynx, trachea or 
bronchus lung section in either cot death cases or paediatric death. 
Fifty four cot death cases showed positive staining to IFN- oC in large 
nuclear phagocytic cells located within the alveoli on sections of 
bronchiole. The highest number of cases showed positivity in 1 - 5 
cells (36%) in cot death cases and the paediatric deaths indicated 2/5 
(40%) of cases were IFN- oi positive in the alveoli.
The positive staining indicative of IFN- oL in the peripheral lung 
section of cot death cases and paediatric deaths is shown in figure 19. 
Non specific staining was noted in the epithelial cells surrounding 
the alveolar spaces. The control slide containing normal sheep serum 
as primary antibody is shown in figure 20.
The number of cases of cot death and paediatric death with positive 
staining in the form of granular brown pigment, specific for IFN- is 
evaluated in Table 43.
Figure 19 Peripheral lung section from Glasgow cot death case (PM 3-48/88) 
stained by the immunoperoxidase technique against IFN- oC (x40)
;Figure 20 Immunoperoxidase staining for sheep antibody in peripheral lung 
section of Glasgow cot death case, PM 3^8/88 (x10)
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OHBCE 42
itelysis cf the Infixed: JiiiairpestrKkfeB lfechfique ifeariLffo; fix IEN- c^ in 
ling Saddens: pharynx, larynx, trachea, hcandxE, braxhinbas from 94 
Glasgow Gbt Dsath Cases and 5 ItefiatrLc Daattis
Grade Values cf Chses with (fells Ibsitfre IEN- oC
Chsa Sectim cf lung 0 (%) 1 (%) 2 (%) 3 (%) 4
jdaarynx 94 0 0 0 0
Oasgow larynx 94 0 0 0 0
Gbt Deaths trachea 94 0 0 0 0
bronchus 94 0 0 0 0
Ixaxhioles 40 (43) 34 (36) 20 (21) 0 0
pharynx 5 0 0 0 0
I&adiatric larynx 5 0 0 0 0
Eeatias trachea 5 0 0 0 0
harnchus 5 0 0 0 0
hccndiioles 3 (60) 2 (40) 0 0 0
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The highest number of positive cells observed in the peripheral lung 
sections from cot deaths was between 1 - 1 0  cells i.e. grade 1 and 2 
comprising 65 cases (69%). Positive cells were noted in the range of 
16 (grade 4) per high power field in the cot death cases but not found 
in the paediatric cases. Two of the 7 cot death cases (28%) with IFN-o< 
positivity in the grade 4 grouping were also noted as virus positive 
cases i.e. RSV, Polio 2. Five virus positive cot death (33%) cases 
were categorised as 11 - 15 (grade 3) positive IFN cells/high power 
field i.e. RSV, Adeno/Polio 3 and Influenza A. The remaining 6 virus 
positive cot death cases were categorised as 2 cases in the grade 1 
range of positivity e.g. Rotavirus, Adeno and 4 cases with no 
positive cells for IFN- o(. e.g. Rotavirus, Polio 2, CMV, Polio/RSV.
No correlation between IFN- cL levels (IU/ml) measured by IRMA in the 
NPA from cot death cases and the staining specific for IFN- o( in the 
lung sections was noted. Hence as the IFN- oi levels in IU/ml increased 
this did not necessarily correlate with a higher positive ratio of 
cells present in the peripheral lung section. The in situ technique 
and IRMA methods of detecting endogenous IFN- c< used a 
quantitative and quantitative analysis therefore analysis was limited. 
From a small study population the paediatric deaths were grouped in
1 - 5  positive cells for IFN- oi (40%) i.e. grade 1 and included one 
virus positive case i.e. RSV. The remaining cases were virus negative 
and also were in the grade 1 category of staining. The cases indicated 
0 IU/ml IFN- oC in the NPA as measured by IRMA.
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7.4.2 IDENTIFICATION OF MACROPHAGE CELT, POPULATION 
BY MONOCLONAL ANTIBODY KP1
The large nuclear cellular particles positively staining for IFN- in 
the alveolar species in the peripheral lung sections from cot death and 
paediatric death cases were identified by using a marker specific to 
the macrophage cell population. The results confirmed that the cells 
positively staining for IFN- oC in the lung sections were from the 
alveolar macrophage cell line. The number of cells staining with the 
brown/blue pigment were counted and an average number obtained over 
five high power fields (x40). The number of macrophage positive cells 
was compared with the number of IFN- oi positive cells and a ratio 
obtained which indicated IFN- ^  positivity in macrophage cells i.e. the 
ratio < 1 indicated that macrophage cell line were cells positive for 
IFN- oC, a value >1 suggested that another group of cells were 
staining positively for IFN- oC . The results of ratios obtained on a 
range of peripheral lung sections are shown in Table 44. All the 
ratios obtained in the cases in this study were <* 1. The IFN- oC 
values in 8 cot death cases and 2 paediatric deaths along with the 
immunocytochemistry and ratio of number of positive IFN- oC cells on 
comparison with the number of macrophage cells present in the 
peripheral lung sections were shown with isolation/detection of virus.
The staining pattern obtained with the monoclonal antibody KP1 in alveolar 
macrophages is illustrated in figure 21.
Figure 21 Staining of alveolar macrophage cells with monoclonal antibody 
KP1 in peripheral lung section of Glasgow cot death case,
PM 348/88 (x20)
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Overall Analysis cf Ei^ it Glasgow Gbt Death Chses and to Ihediabric Deaths cn 
IhrestLgatim cf Iixg Sectim for UN- o( .
Case
Vicus
Pressit
UN- o( (u/ral) 
in NPA
Gads cf 
Staining
NLrrber 
cf Jtocphage Ratio
Gbb Deaths 1 Mluanza A 240 3 (12) 25 0.48
2 RSV 20 3 (11) 21 0.52
3 A3ax/BaLiD 15 3 (13) 19 0.68
4 RSV 0 3 (14) 31 0.45
5 Ebljta 0 0 22 0
6 Nagatire 52 4 (21) 40 0.52
7 tsfegative 0 0 2 0
8 Adax/Rota 0 1 ( 2) 12 0.16
tetiiatric
Daaths 9 RSV 20 1 ( 3) 9 0.3
10 Native 0 0 6 0
161
7.4.3 PATHOLOGICAL AND BMJNOCTTOCHEmC&L ANALYSIS
Histology reports, obtained from the pathologists, relating to the 
individual lung sections: pharynx, larynx, trachea, bronchus,
bronchioles and peripheral lung from Glasgow cot death cases were 
analysed with respect to the results of IFN- oC detection by the in situ 
technique as in section 2.1.9.
No pathology of note was detected in the pharynx, larynx, trachea, 
bronchus and bronchioles. The reports indicated that these sections 
had no significant abnormality, normal submucosal lymphoid tissue and 
mild lymphoplasmacytic submucosal infiltrate. The cot death cases with 
IFN- oC detection by the immunoperoxidase method in grades 1 and 
2 of positivity in cells were reported as normal lung parenchyma, 
lymphocytic infiltrate and subpleural petechiae.
However, the cases with grades 3 and 4 staining in the peripheral lung 
section were categorised as congested, oedematous with eosinophilic 
necrosis, lobular consolidation and early bronchopneumonia. From the 22 
cases in the category grades 3 and 4, 18 cases (75%) indicated positive 
findings by histological observation in the peripheral lung sections.
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CHAPTER 8 
FINAL DISCUSSION
Research workers looking for the aetiological causes of the sudden 
infant death syndrome or unexplained death have followed two lines of 
enquiry. Initially, epidemiological surveys were carried out to 
assess the factors associated with a higher risk of cot death.
These have not been conclusive, but have been helpful to bring the 
syndrome into perspective. The second pathway has searched for a 
defined cause for sudden death in infants < 1 year of age, and utilised 
clinical and pathological investigations in multidisciplinary 
research programs.
The present multicentre study merged both pathways in order to 
gain further knowledge and data on the infection theory proposed for 
cot death cases. The suggested hypothesis that infection by an 
undefined microorganism may lead to the triggering of a mechanism in 
the final pathway leading to sudden unexplained death in infants was 
popularised in the 1970's (Scott et al.,1978, Uren et al., 1980).
The theory had lost some favour with research workers due to the 
unrewarding results of virological studies in cot death cases.
In the present study, the detection of alpha interferon has been 
applied to samples obtained from cot death and paediatric death cases.
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The additional pathological investigations of impression smears and 
cytospin preparations were used to aid the detection of respiratory 
viruses in lung sections. However, the viral positivity rate for cot 
death cases i.e. 16% in Glasgow cases and 38% in Edinburgh cases were 
not dissimilar from the documented values found elsewhere. A feature 
of note was the high proportion of respiratory viruses eg. RSV, influenza 
virus type A, rhinovirus, parainfluenza type 3 in the total viruses 
isolated/detected (Tables 18 and 20).
In the paediatric death group an 18% viral positive rate was found 
(Table 18) and again the largest proportion of viruses detected were 
frcxn the respiratory tract. The RSV positive cases of cot death and 
paediatric deaths presented during the RSV epidemic of the winter of 
1987 and 1988 in Scotland. The significance of the respiratory results 
will be dealt with in more detail on discussion of the demographic 
survey.
The poliovirus isolates as a group accounted for more recovered viruses 
than any other isolate obtained from the cot death cases. These isolates 
were almost certainly vaccine strains. Persistent excretion of oral 
polio vaccine strains for several weeks is widely accepted (Philip Minor, 
personal communication). Evidence relating the Glasgow infants who had 
been immunised to the positive poliovirus isolation results was 
obtained despite the small number of complete reports of vaccine history.
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The number of poliovirus positive cot death cases per annum in this study 
were similar to those documented in the pathological reports, RHSC, Glasgow, 
1979-86 (Patrick et al., 1989).
The significance of finding poliovirus in specimens from cot deaths was 
considered to be doubtful from the results presented in this thesis.
These findings correlated with Roberts (1987) published data supporting 
the view that there was no link between sudden infant death and 
DTP-polio vaccination.
The present analysis recorded a wide variety of viruses for cot death 
cases. This factor highlighted the observation by Urquhart and Grist 
that no one particular virus was responsible for cot deaths.
The serological analysis undertaken gave no valuable insight into a 
possible virus aetiology. Although the number of viruses screened was 
small, they were those routinely tested in virus laboratories as 
responsible for clinically significant disease.
As part of the analysis of this prospective study a demographic survey 
of the cot death data from both Glasgow and Edinburgh was documented.
The survey pinpointed several useful parameters as background 
information to the study group. Cases brought to the Pathology 
Departments as suspected cot death were consistent in numbers for each 
year studied i.e. 40 cases in 1987 and 1988, and therefore confirmed
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incidence rates for Scotland as published by Ameil and colleagues
(1985).
The cases were categorised (see section 2.1) as in previous studies to 
indicate the "true" cot death group and enable cross reference with 
retrospective and prospective data.
The cot death cases, all less than one year of age covered a wide age 
distribution within the twelve month span. The highest number of cases 
were in the age grouping 9-16 weeks, a factor noted by Patrick and 
coworkers (1989) at the Pathology Department, RHSC, Glasgow.
Evidence of increased monthly distribution during the winter months 
November - April and early increase in numbers of cases in the months 
September and October for Glasgow and Edinburgh cases are presented. A 
significant decrease in the numbers of cot death during the months 
June-July further highlighted the winter increase. This coincided with the 
paediatric respiratory epidemic of RSV during the two year study 
period, although relatively small numbers of RSV positive cases were 
detected in the samples from cot deaths. From these observations it 
would seem unlikely that cot deaths are caused principally by RSV but 
does not rule out an as yet unidentified virus prevalent in winter 
months. These conclusions are ratified in the literature (Nelson 
et al., 1975).
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Mild infection in 60% of cot death cases before death was reported.
This figure would not be unreasonable in this situation as infants are 
susceptable to a wide range of pathogens from the earliest age.
The location of cot death within the cities investigated showed a 
random distribution pattern. The increase in numbers of cases in areas 
with dense populations was noted in postcode areas G33, 
Blackhill/Riddrie, G34, Easterhouse,EEfl 6 , iLiberton^ EH4, 
Silverknowes/Clemiston. The population statistics for these postcode 
areas of Glasgow and Edinburgh contradicted any increases in numbers of 
cot deaths due to high residency and higher birth rates in these 
locations (Figures 6 and 9).
Comparisons of the cot death group and the adult and paediatric death 
specimens were useful in a study of this type in order to make some 
limited observations of the normal population. The present study 
included a paediatric death group, referred to as such and not as a 
specific "control11 group due to the lack of common factors.
It is the long held view of workers in the field that no appropriate 
"control" group exists for the study of cot death. For the purposes of 
the present study, the most appropriate "control" group would have been 
a group of infection free infants, age and sex matched to the cot 
deaths. For ethical reasons, taking clinical specimens from infants 
apparently healthy was not possible.
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The group of infants thought to be a good comparative group for the cot 
death infants are 11 near miss" infants, however the numbers are small 
(Golding et al., 1985). The paediatric death cases analysed were all 
hospital based prior to death and hence had scxne intrinsic abnormality 
or disease.
The additional work and relative novel approach presented in this thesis 
corresponded to the detection and analysis of IFN- oC in biological 
fluids from cot death cases. Interferon as an acute phase protein is 
induced by a variety of stimuli including viruses and has been shown to be 
part of the initial response of the host to acute viral infection.
The assay system used in this project to detect the presence of IFN-o^ 
was evaluated for sensitivity and specificity during a series of 
experimental investigations(Tables 4, 5, and 6). The specificity of 
the assay was investigated by a neutralisation/blocking assay on standard 
preparations (Figures 4 and 5, Table 6) and subsequently on the test 
samples (Tables 7 and 8). The results demonstrated the monoclonal antibody 
to IFN- oC to be specific in standard preparations and the specimens 
tested.
Values of IFN- oC. in samples from cot deaths and paediatric deaths 
were evaluated and found to be reliable at levels of > 1 IU/ml. The 
sensitivity of the IRMA was greater than biological assay systems 
used in other projects relating interferon in cot death cases
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(Seto & Carver, 1978, Vanacek et al., 1986).
The detection of IFN- o£ at relatively low levels i.e. <10 IU/ml 
(Table 27) in cerebrospinal fluid samples from cot death cases and 
paediatric cases was interesting as the viral culture results from the 
brain and CSF samples were negative (Tables 18 and 20). The highest 
numbers of cot deaths and paediatric deaths were observed in the same 
IFN- oi range 1.1 - 10 IU/ml and these groups indicated comparable mean 
values of IFN- oC (Table 26 and 27). Conclusions from these observations 
showed no significant difference in CSF IFN- lvalues for the two study 
groups. No identifiable cause of acute infection was found although 
the levels were comparable with those detected in a group of patients 
presenting with viral meningitis (Ho Yen & Carrington, 1987). However 
other pathological features of meningitis were absent from the cot 
death group or the paediatric group and it is uncertain as to why the 
interferon level was raised in these groups.
The data presented in this thesis is consistent with the view 
that as IFN- o( is detected in the cuboidal epithelium of the choroid 
plexus. The IFN- (A may be synthesised at this location and released 
into the CSF during viral infection (Khan et al., 1989), as opposed to 
release by inflammatory cells recruited into the area of infection.
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The blood brain barrier is a selectively permeable membrane which does 
not normally allow leakage of interferon in either direction. This 
implies the endogenous generation of interferon within the CNS, i.e. 
during virus infection or other triggers. The significance of the 
presence of IFN-c<in the choroid plexus is at present not understood 
and may have a metabolic rather than anti-viral function. However, 
during leakage of serum fluids over the blood-brain barrier during 
meningitis, tissue injury or during death, IFN- o( may gain access to the CSF. 
Interestingly, data generated from the testing of CSF samples obtained 
from adult deaths indicated that 80% of cases had detectable levels of 
IFN- oC present. These cases were reported as "infection free" hence 
the presence of IFN- oC highlights the hypothesis that this protein may 
be produced as part of a metabolic event during death. It is clear 
that IFN- c< present in CSF in life and after death may be derived by 
alternative mechanisms which may not be always infection related.
The infants investigated in the study were analysed for age 
distribution as a contribution to the presence of increased IFN- oC 
levels in the variuos fluid samples tested. No conclusive evidence was 
found to suggest a positive relationship with age (Tables 36 and 37).
A small percentage of cot death cases have serum IFN- oi levels >10 IU/ml 
(5%) a feature not noted for the paediatric death group. The low levels 
of serum IFN- oC in the cot death cases is not likely to be retained 
from the placental transfer or amniotic fluid in late pregnancy
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especially as the half life of IFN- oi is a matter of hours. However, 
the possibility of a neonatal or congenital virus infection inducing 
circulating IFN- oi cannot be ruled out to account for some cases with 
high IFN- oi levels.
The NPA samples collected from cot death cases, both Glasgow and 
Edinburgh were positive at levels >10 IU/ml in • 35% of the
cases, although paediatric deaths showed i evidence at 14% for IFN-oC 
>10 IU/ml (Table 21). These results were confirmed in the mean values 
of IFN- oi documented in Table 22. Evaluation of the cot death data in 
conjunction with the clinical data generated at the Virology 
Laboratory, RHSC, Glasgow by Salas (1988) indicated . ; a similar 
range of IFN- oi values to those in pneumonia and chronic lung disease. 
Bronchiolitis cases and upper respiratory tract infection similarly 
analysed did not show a similar range of IFN- oi values when compared 
with cot death NPA samples. These results are remarkable as they may suggest 
that the cot death cases were in the very earliest stages of acute 
respiratory infection, prior to significant clinical symptomatology and 
inflammatory disease. This data provides an interesting perspective to 
this syndrome which has so far failed to provide an identifiable marker 
of disease.
The qualitative detection of IFN- oi in positively stained cells in 
the peripheral lung by immunocytochemical methods did not correlate
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with the raised IFN- c/- values noted by IRMA (Table 44). Samples 
of NPA for IRMA testing were obtained from the upper respiratory tract 
while sections of the lower respiratory tract were investigated by 
immunocytochemical staining. Qualitative evidence of IFN- oC 
staining therefore could not be directly correlated with the 
quantitative IFN- oC values observed in the NPA.
IFN- o£ was detected in this study in the alveolar macrophages in the 
peripheral lung sections (Figure 21). The source and role of these 
interferons are still unclear. Recent work has investigated the role 
of IFN- oC from the mononuclear cells and indicated that these cells 
may be the main immunological cells of the primary response to viral 
infection, thereby releasing low levels of endogenous IFN- oC . 
Published data showed that the presence of lymphocytes and mononuclear 
cells, in particular the alveolar macrophages in the tissues would 
enable local production of IFN-oCin vivo by these cells after 
induction by the appropriate agents (Bocci, 1988).
The analysis of raised IFN- oC values in the NPA, serum and CSF and 
the 'post mortem interval1 indicated that there was no increased 
likelihood of obtaining high levels of IFN- oL as time progresses after 
body death. These results counter the suggestion that the presence of 
IFN- cL in the cot death cases was due to tissue injury and subsequent 
release of interferons(directly or indirectly).
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The presence of endogenous IFN- oi in virus positive cot death cases 
and paediatric deaths was documented in detail (Tables 32 and 33). 
Significant levels of IFN- oi (i.e. > 10 IU/ml) were observed in NPA
but not in serum or CSF. Specimens tested for IFN- oi during proven 
acute viral infection have indicated raised levels in these clinical 
samples, and its presence in cot death specimens raises further 
suspicion in support of the infection hypothesis. On first analysis 
raised IFN- oi values in the NPA samples would appear to indicate that 
the 30% positivity rate for respiratory viruses in the cot death cases 
were confirming the isolation data. However, the raised IFN- oi 
levels were not exclusively from the proven respiratory cases suggesting 
that isolation/virus detection systems are underestimating the total 
virus load in true respiratory tract infection of these infants.
It was clear from the results that as the cot death cases and paediatric 
deaths reported as virus positive had raised IFN- o( values in the body 
fluids in only 50% of cases it was equally likely not to find IFN-c*' 
in these cases. This is a worrying statistic if this assay was used as 
the sole marker of viral disease.
It was surprising that in virus negative cases raised IFN- oi levels 
were seen in all three samples tested (Tables 35 and 36). This is 
further evidence to highlight the need to consider viruses as yet 
“not identified", or conventional diseases at an early stage 
before detection by the clinician, pathologist or virologist.
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It is clear from this study that conventional approaches to virus 
detection by tissue culture techniques and serology provide little 
useful data to the aetiology of cot death. A wide range of viruses is 
seen with no predominant type. However, the winter increase of cases 
and the summer low is such a regular feature of cot deaths throughout 
the world that a microorganism transmitted in the winter season must 
still be considered. The interferon data provided in this study goes 
some way to suggest that an as yet unidentified agent may exist, and 
if so, it is likely to be respiratory pathogen.
Raised interferon levels were consistently found in NPA samples from 
cot death cases in the two geographical locations and over two years of 
study. These levels are comparable with studies where clinical lower 
repiratory tract infection is suspected or proven, despite the absence 
of clinical or pathological signs of disease in cot deaths. This dilemma 
highlights the dilemma of the sudden infant death syndrome- a death in 
an apparently healthy baby.
Although this thesis is by no means conclusive, it points to interferon 
inducing agents released around the time of death in the majority of 
cot death cases and thus requires an explanation. An unidentified 
virus is as plausible as ever, but clearly it would be one with unusual 
properties and disasterous consequences. It is premature to discount 
the infection hypothesis.
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